Register for our upcoming webinars or browse our on-demand webinar library to hear from experts who are breaking ground in their fields of scientific research. You will learn about the newest tools and technologies while gathering valuable tips and troubleshooting strategies for the applications most relevant to your processes.
No search results
Try changing or broadening your filter criteria.
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Calcium Carbonate as TiO2 Alternative in Coating: The Importance of Particle Engineering
This webinar highlights how particle-engineering supports an optimal performance of calcium carbonate in coating applications, comparing our new alternative to titanium dioxide, the industry benchmark.
Almut von der Brelie
Merck
Senior Manager Strategic Marketing, Excipients for Solid Applications
Thomas Kipping, Ph.D.
Merck
Head of Drug Carriers
Analytical chemistry, Large molecule HPLC
Exploring Oligonucleotide Diversity: Insights From Multiple Modes of Chromatography
Discover multiple modes of chromatography and method parameters to comprehensively characterize oligonucleotides.
Cory E. Muraco
Merck
Biomolecule Workflows Manager
Andrea Krumm
Tosoh Bioscience GmbH
Product Manager, Analytical Columns
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Advancements in Clinical Nutrition: Targeting Hyper-homocysteinemia with B-vitamins
In this webinar, we will discuss advancements in clinical nutrition, with attention spent on the deficiency of B-vitamins and targeting hyper-homocysteinemia in chronically and critically ill people.
Rima Obeid, Ph.D.
Central Laboratory, Saarland University Hospital
Professor, Department of Clinical Chemistry and Laboratory Medicine
Jean-Pierre Knapp
Merck
Senior Scientist, Analytics Quality Services
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Enabling Upstream Intensified Bioprocessing with our New Mobius® iFlex Bioreactors
In this webinar, you will learn how our new single-use bioreactor family can help you fulfill your process strategy, facilitate scalability of your upstream process, and utilize the flexible design to reduce production costs.
Samantha Whitney
Merck
Applications Engineer
Kristen Der
Merck
Associate Product Manager
Analytical chemistry, Low pressure liquid chromatography
Leverage the full potential of Pharmacopeia regulated U/HPLC method adaption to increase lab effectiveness
Learn strategies to improve productivity and reduce costs in your pharmaceutical analyses with U/HPLC method adaptation.
Petra Lewits
Merck
Global Product Manager for Analytical Chromatography, HPLC columns
Egidijus Machtejevas
Merck
Sr. Technical Advisor, Analytical Chromatography Workflows
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Pioneering eData Exchange for Quality and Regulatory Data with StaQRD™
In this webinar, you will discover a new era of streamlined communication and automation, enhancing industry collaboration.
Sebastian Aurich, Ph.D.
BASF Pharma Solutions
Global Regulatory & Quality Compliance
Stefan Brohm
Merck
Manager Digital Products
Andreas Hildesheim, Ph.D.
BASF Pharma Solutions
Senior Global Product & Marketing Manager
Marius Stoffels, Ph.D.
Merck
Product Owner - Digital Solutions
Pharma and biopharma manufacturing, mRNA
mRNA Powering Life Changing Therapies
In this webinar, join industry experts to learn about strategies to accelerate mRNA therapies and enable scalability and process efficiency from preclinical to commercial.
Andrew Geall, Ph.D.
Replicate Bioscience
Chief Development Officer
Conner Feldman
Merck
Strategy Manager, Emerging Modalities
Jason Sterling, Ph.D.
Merck
Global Business Lead, Product Characterization
Bastian Rouven Brückner, Ph.D.
Merck
Head of Operations
Aditi Mehta, Ph.D.
Merck
Associate Director, Head of mRNA Process & Delivery
Pharma and biopharma manufacturing, Gene therapy manufacturing
Strategies to Accelerate Development and De-risk Gene Therapy Manufacturing
Join our viral vector PAD experts as they showcase strategies for developing robust processes and analytics for efficient and de-risked manufacturing.
Hugh Murray
Merck
Upstream Scientist
Michael Born
Merck
Senior Scientist
Dayne Callum
Merck
Senior Scientist
Chemistry and synthesis, Reaction design and optimization
Novel Approaches in Organic Synthesis
Discover Greener Modalities in Catalysis complementing classical transition metal-based approaches like cross-couplings, C-H functionalization, and metathesis.
Angelo Lanzilotto
Merck
Technology Manager Chemistry Innovation
Pharma and biopharma manufacturing, Liquid Formulation Strategies
Thermostabilizers: Protecting Vaccines Upon Cold Chain Breaks
In this webinar, you will learn about the challenges involved in the delivery of vaccines to developing countries and potential risks as well as how using conventional and new excipients can stabilize protein vaccines in liquid and in solid vaccine formulations upon short-term cold chain breaks.
Michelle Pascale Zoeller
Merck
Senior Scientist
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Managing Nitrite Impurities: A Combined Supplier-Manufacturer View to Nitrosamine Risks
This webinar will review the current regulatory considerations, the role of nitrites, and the analytical controls as well as the view of a drug product manufacturer on the related risk mitigation strategy.
Ulrich Reichert, Ph.D.
Merck
Global Regulatory Management
Joerg Schlingemann, Ph.D.
Merck
Director, Global Quality Control Principal Expert
Sebastian Hickert, Ph.D.
Merck
Senior Manager for Analytical and Preparative Liquid Chromatography
Protein biology, Protein labeling and modification
TPD webinar-global
Our upcoming webinar titled "Innovative Approaches for Targeted Protein Degradation" will showcase our comprehensive portfolio of products, ranging from complete to partial PROTACs, E3 engagers, and individual linkers, which support researchers in all stages of PROTAC® studies.
Angelo Lanzilotto
Merck
Technology Manager Chemistry Innovation
Carmela Foti
Merck
Technology Manager
Cornelia Roessler
Merck
Technology Manager
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Envisioning New Concepts for Pharmaceutical 3D Printing and Solubility Enhancement
In this webinar, we will introduce a new concept for additive manufacturing of challenging oral dosage forms.
Thomas Kipping, Ph.D.
Merck
Head of Drug Carriers
Michelle Schilling, Ph.D.
Aprecia Pharmaceuticals
Product Development Manager
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Take the Reins of Your AAV-based Therapy: Ensuring Safety with Cell-based Analytical Testing
In this webinar, we’ll discuss the biology of AAV-host cellular interactions and the cell-based assays that can be used to establish product safety and infectivity.
Anna Woodward, Ph.D.
Merck
Senior Technical Specialist
Cari Sadowski
Merck
Principal Virology Scientist
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Scaling for Commercialization: Considerations for Large-Scale API Production
In this webinar, we take a look inside our latest capacity expansion for large-scale GMP API production located in Darmstadt, Germany.
Bertram Cezanne, Ph.D.
Merck
Department Head of Process Development
Bertram Barnickel, Ph.D.
Merck
Director, Head of Value Stream Management
Ulrich Reichert, Ph.D.
Merck
Global Regulatory Management
Jacqueline Ruff
Merck
Strategic Marketing Manager
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Multi-Targeting Fc-Fusion Proteins to Accelerate Clinical Development through GI-SMART Technologies
In this webinar, GI Innovation, Inc will discuss its SMART-Selex and SMART-cLego technologies.
Dr. Young Min Oh
GI Innovation
Managing Director
Hojae Lee
Merck
Technical Application Consultant
Pharma and biopharma manufacturing, Gene therapy manufacturing
AAV Upstream Process Development: A Collaboration with Synplogen Japan
In this webinar, our partner, Synplogen, will share their experience in developing a robust and scalable upstream AAV platform for gene therapies.
Shunsuke Saito
Synplogen
Director, Medical Business Unit
Kentaro Hayashi, Ph.D.
Synplogen
Head, DNA Synthesis Business Unit
Yoshinori Takagi, Ph.D.
Synplogen
Officer, Medical Business Unit R&D
Pharma and biopharma manufacturing, Detecting & Removing Aggregates
How to Prevent Protein Aggregation through Stabilizers and Surfactants
This webinar will provide a comprehensive overview of protein aggregation, underlying mechanisms and stabilization techniques using (novel) excipients in parenteral formulations.
Michelle Pascale Zoeller
Merck
Senior Scientist
Can Araman, Ph.D.
Merck
Senior Manager, Lab Head
Pharma and biopharma manufacturing, Monoclonal antibody manufacturing
Accelerated Monoclonal Antibody Development: Advance from Transfection to GMP Drug Substance in 9 Months
In this webinar, you’ll hear from some of the experts who were instrumental in developing the Accelerated mAb development program and work with our biotech clients on a daily basis to accelerate their timelines towards production of GMP drug substance.
Armelle Gilletta de Saint Joseph
Merck
Analytical Laboratory Supervisor
Angéline Rodrigues-Antunes
Merck
Operational QA Expert
Jean-Baptiste Noirot-Cosson
Merck
Head of Manufacturing Science and Technology, Biologics CDMO
Emilie Cester
Merck
DSP Development Expert
Carole Monerie-Moulin
Merck
DSP Innovation Expert
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Refresher on Excipient Regulations and Processes to Facilitate Drug Product Registration in China
In this webinar, you will learn how to navigate the registration and co-review process of excipients as well as how to deal with excipient related challenges during the drug approval process in China.
Yuwei Heinzel
Merck
Head of Pharma Registration, Germany
Cloris Tian
Merck
Senior Regulatory Manager, Greater China
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
From Myth to Mastery: Unveiling the Secrets of Virus Bank Manufacturing
In this webinar, using case studies and real-life examples, we will walk you through the GMP manufacturing steps. From starting material to GMP bank and support engineering runs, through to technical transfers, we will review how to best approach the virus bank manufacturing process and overcome common obstacles.
Angela Waugh
Merck
Global Scientific Lead, Manufacturing Value Stream
Scott Gorman
Merck
Scientific Supervisor, Manufacturing Department
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Intensified Capture of Monoclonal Antibody by Harvest Concentration by SPTFF
In this webinar, we will provide guidance and best practices for assessing different approaches to maximize the benefits of SPTFF concentration and improved productivity of an intensified protein A capture step.
Akshat Gupta
Merck
Associate Director, Global BioPharma Center of Excellence
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Managing Endotoxins - Detect, Prevent, Remove
In this webinar, you will learn how to managing endotoxins, including possible endotoxins contamination sources during manufacturing and strategies for endotoxin removal.
Markus Greulich, Ph.D.
Merck
Strategic Marketing Manager, Excipients Liquid Application
Subhasis Banerjee, Ph.D.
Merck
Principal Bioprocessing Application Expert
Brittany Gall
Merck
Strategic Marketing Manager, Upstream Chemicals
Prateek Garg
Merck
Global Segment Marketing Manager, Small Molecules
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Kick It Off Right: A Successful Cell Bank Manufacture
In this webinar, you will understand when you need a Master Cell Bank (MCB), your Working Cell Bank(s) and other such as Cells at Limit (CAL) or End of Production (EOP) cell bank, how to make the most of your bank and how we can help you.
Angela Waugh
Merck
Global Scientific Lead, Manufacturing Value Stream
Mee Chee Lee
Merck
Sales Development Manager, Upstream Services, Asia Pacific
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Evaluating USP 665 for Extractables Testing and Reducing Animal Testing for Biological Reactivity
In this webinar, you will learn about the new and changing compendial methods and what it means for pharmaceutical manufacturing.
Jessica Shea
Merck
Emprove® Program Manager
Katharina Christlieb
Merck
Senior Marketing Operations Manager
Pharma and biopharma manufacturing, Viral Vector Vaccine Manufacturing
Industry-leading Lentiviral Titers through our Optimized VirusExpress® Production Technology
Hiral Gami
Merck
Upstream Scientist - Viral Vector Technology and Innovation
John Mumira
Merck
Application Scientist - Viral Vector Technology and Innovation
Paul Turiano
Merck
Scientist - Viral Vector Technology and Innovation
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Sustainable Alternatives to Triton™ X-100 for Biomanufacturing, the Deviron® Portfolio
In this webinar, we will show you the features and the application data of our portfolio of sustainable and biodegradable alternatives to Triton™ X-100, the Deviron® detergents.
Alice Antonello, Ph.D.
Merck
Senior Scientist - Bioprocess Chemistry
Sarah Lechat
Merck
Global Strategic Marketing Manager
Pharma and biopharma manufacturing, Gene therapy manufacturing
Holistic Approach to Optimize Viral Vector Harvest
This webinar will give you some fresh insights into the viral vector harvest step. The speakers will provide an overview of the aspects and the unique challenges around viral vector harvest, from detergent candidates and DNA digestion optimization to key points in designing clarification and purification at the downstream process.
Meghan Peng
Merck
Biopharm Materials Technical Application Expert
Yuki Tsunakawa
Merck
Downstream Technical Application Expert
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Breaking the Boundaries of Biomolecule Separation with BIOshell™ UHPLC Columns
Cory E. Muraco
Merck
Biomolecule Workflows Manager
Pharma and biopharma manufacturing, Viral Vector Upstream Processing
Process Development and Intensification for Ultrafiltration/Diafiltration of Viral Vectors
In this webinar, we will explore two operating strategies, transmembrane pressure (TMP) and permeate control, while considering their impact on process time, viral yield, and impurity removal.
Anand Alembath
Merck
Development Engineer
Rosario Cervellere
Merck
Applications Engineer
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
What’s Really in the Box? Characterizing AAV Encapsidated Nucleic Acid Sequences Using NGS
In this webinar, we discuss characterization of several representative AAV molecules using NGS, including the sequencing process, bioinformatic analysis, and representative results.
Bradley Hasson
Merck
Director of Lab Operations for NGS Services
Analytical chemistry, Wet chemical analysis
Karl Fischer Titration Series
Bettina Straub-Jubb
Merck
Global Product Manager, Karl Fischer Titration
Michael Margreth
Metrohm AG.
Application Specialist - Karl Fischer Titration and Water Determination
Dr. Shailly Krishna-Rajusth
Merck
Global Product Manager, Physical & Chemical Property Standards
Thomas Hitz
METTLER TOLEDO
Application Chemist
Angela Schwehn
Merck
Chemical Laboratory Technician
Pharma and biopharma manufacturing, Detecting & Removing Aggregates
Building Better Degraders: Targeted Protein Degradation Partners from Lead Discovery to Production
In this webinar, we will focus on the latest advances in chemical building blocks for protein degradation, including warheads, linkers, and ligands, and how they can be used to build better degraders.
Aditya S. Vaidya
Chemical Biology Innovation
Senior Scientist
Hugo Matos Viana
Merck
Global Product Manager - Chemical Biology
Jason Modest
Merck
Director of Manufacturing, Science and Technology
Jacqueline Ruff
Merck
Strategic Marketing Manager
Pharma and biopharma manufacturing, Liquid Formulation Strategies
Material Attributes of Poloxamer 188 Affecting the Application in Liquid Protein Formulation
Poloxamer 188 finds wide application in the development and manufacturing process of pharmaceutical drug products. In this webinar, we will show how the performance of PLX188 in these applications can be affected by variations in molecular weight or hydrophobicity, observed among different batches or products.
Nelli Erwin, Ph.D.
Merck
Senior Manager, Head of Protein Stability
Alice Antonello, Ph.D.
Merck
Senior Scientist - Bioprocess Chemistry
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Transforming the Biopharma Supply Chain, eData Solutions for Agility and Manufacturing Efficiency
This webinar will discuss how eData enables process automation and simplification, including critical analytics and logistics data from suppliers of raw materials and production consumables.
Chang Ge
Merck
Product Manager, Logistical Services
Prithwiraj (Prith) Das
Merck
Manager, Customer Success, Analytical & Logistical Services
Microbiological testing, Bioburden testing
The Route to Faster Microbial QC with the Milliflex® Rapid System 2.0
Anne-Grit Klees
Merck
Global Product Manager Environmental Monitoring
Esther Welterlin
Merck
Validation Expert
Carine Krebs
Merck
Global Product Manager Services
Pharma and biopharma manufacturing, Liquid Formulation Strategies
Solubility Enhancement of Poorly Soluble Drugs Guided by the Developability Classification System
This webinar will provide you with an overview on the DCS and different formulation strategies as well as a deep-dive into hot-melt extrusion technology and which excipients are suitable for this process.
Markus Lubda, Ph.D.
Merck
Strategic Marketing Manager
Nadine Gottschalk
Merck
Principal Scientist
Pharma and biopharma manufacturing, mRNA
mRNA Webinar Series
mRNA technology offers many opportunities but the development and manufacturing of mRNA-based vaccines and therapeutics present a number of challenges. Learn more about the opportunities of the mRNA technology and how to overcome drug development and manufacturing challenges to bring your mRNA-based therapies to market in this series of webinars.
Julian Mochayedi, Ph.D.
Merck
Strategic Marketing Manager for mRNA Solutions
Eike Joest, Ph.D.
Merck
Principal Scientist for mRNA Innovation
Martin De Cecco, Ph.D.
Merck
Technology Lead, Product Characterization
Amy Glekas, Ph.D.
Merck
Global Business Lead, NGS and Novel Modalities
Materials science and engineering, Batteries, supercapacitors, and fuel cells
Powering a Sustainable Future with Advancements in Battery Development
Powering a Sustainable Future with Advancements in Battery Development Join us to explore the latest advancements in energy storage, from composite electrodes to post-Li-ion batteries.
Axel Groß, Prof., Ph.D.
Helmholtz-Institute Ulm (HIU) Electrochemical Energy Storage, 89081 Ulm/Germany
Prof., Ph.D.
Adam Raw, Ph.D.
Merck
Head of Materials Science R&D of Merck
Pharma and biopharma manufacturing, Viral Vector Vaccine Manufacturing
Streamlining Viral Vector Development & Manufacturing for Gene Therapies
Join our viral vector experts to learn more about our capabilities and solutions for gene therapy production as they highlight key features of our technologies and infrastructure through a virtual tour of the GMP manufacturing facility.
Erik Amundrud
Merck
Sr. Manufacturing Manager
Materials science and engineering, Drug delivery
Ultrapure Alginates: Properties and Applications in the Biomedical Field
Then join us for a fascinating webinar on the potential of alginates in cell-based immunotherapy and 3D bioprinting. Our presentation will provide an overview of ultrapure alginates and their unique molecular properties, as well as showcase specific studies that demonstrate their versatility and potential applications. Don't miss out on this opportunity to learn about the tunable gelation behavior of alginates and their potential to revolutionize the field of biomedical engineering.
Dr. Marizela Delic-Schlumbohm
IFF Pharma Solutions
Associate R&D Manager
Susan Jordan, PhD
IFF Pharma Solutions
Technical Fellow
Pharma and biopharma manufacturing, Cell therapy manufacturing
A Single-Use, Scale Down, Predictive Solution for Intensified Perfusion Development
In this webinar, you will learn about a new microbioreactor platform and its capabilities and applying the technology to determine CSPR for specific cell lines as well as predicting process scalability.
Kevin Lee
Merck
Co-founder of Erbi Biosystem
Quang Long Pham, Ph.D.
Merck
Senior Scientist, Innovation-Cell Culture Media Development (ICMD), Bioprocessing Upstream R&D
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
CHO Fed Batch Process Simplification Using Cellprime Growth Factors and Innovative Chemicals
In this webinar, you will learn about CHO cell culture media components, non-animal origin growth factors, and the usage of modified amino acids for fed batch simplification.
Sateesh Poojari
Merck
Sr. Technical Application Expert
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Advancements in Process and Payload Development for ADCs and Next-Generation Bioconjugates
We invite you to a series of presentations on process and payload innovation for ADCs and bioconjugates.
Melissa Ritchie
Merck
Senior Scientist, Analytical Development
Sowmyan Sreenivasaraghavan
Merck
Scientist, ADC Process Development
Jake Spies
Merck
Senior Scientist Group Lead Process & Analytical Development
Haowei Song
Merck
Principal Scientist in Novel Modalities R&D
Ross Bemowski, Ph.D.
Merck
Associate Director of Analytical Development
Kaelyn Wilke
Merck
Associate Director, ADC & Bioconjugation Services
Food and beverage testing and manufacturing, Regulatory compliance
Risk Assessment for Carcinogenic Substances in the Lab
Want to learn more about how to identify carcinogens, Discover various technical protective measures for minimizing exposure in labs, Register for the Webinar.
Dr. Birgit Stoeffler
Merck
Safety Specialist, Expert in the Committee on Hazardous Substances
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Maximizing the Value of Your AAV Using Small Volume AAV Testing
Join this webinar to learn our approach to method development where we can measure more than one AAV CQA within a single analytical run. This small volume AAV testing package reduces the amount of test material required so you can treat more patients.
Jason Sterling, Ph.D.
Merck
Global Business Lead, Product Characterization
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
How to Bring Your LNP Formulation to Clinical/Commercial Manufacturing via CTDMO Services
Covid-19 vaccines have demonstrated the clinical potential of mRNA-Lipid Nanoparticle formulations. To enable the development of next-generation lipid-based drug delivery systems, expertise and manufacturing capabilities are critical. Learn more by watching this webinar.
Mahesh Karwa
Merck
Associate Director, Process Development
Teresa Demuth
Merck
Strategic Marketing Manager
Food and beverage testing and manufacturing, Microbiological analysis
New EN ISO 7704:2023 on Membrane Filters for Microbiological Water Analysis
Join our upcoming webinar on EN ISO 7704:2023, a mandatory standard that affects all ISO 17025 accredited laboratories performing microbiological analysis of water samples by membrane filtration. You will be informed about the new requirements of this recently published standard that has replaced EN ISO 7704:1985, and about solutions for your lab to meet the challenge.
Barbara Gerten
Merck
Senior Scientist Traditional Microbiology
Andreas Bubert, PhD
Merck
Senior Product Manager, Culture Media Food & Beverage
Samuel Soriano Santiago
Merck
Global Product Manager
Analytical chemistry, Filtration
The Art of Filtration
Mastering the Art of Filtration: A Webinar Delving into the Nuances of Filtration Techniques for Improved results in Analytical Chemistry and Cell Culture.
Uwe Wagner
Merck
Technology Manager
Dr. Anke Kleiser
Merck
Technology Manager
Pharma and biopharma manufacturing, Downstream Processing
Best Practices of pDADMAC Flocculation for a Successful GMP Biomanufacturing
pDADMAC flocculation is a promising solution to challenges in clarification of high cell density cultures, yet its use in GMP biomanufacturing still has points to be clarified. This webinar will address pDADMAC questions, including DoE, risk assessments and clearance tests.
Yuki Tsunakawa
Merck
Downstream Technical Application Expert
Takuro Hozumi
Merck
Process Development Scientist
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Client Case Study: How an Optimized Purification Platform Can Speed mAbs Clinical Production
Getting your antibody to clinical trials faster while being able to build a robust, scalable, and high-yielding process is a challenge many biotech companies face. By outsourcing to a CTDMO, you can benefit from an optimized platform process. In this webinar, we will showcase our purification development platform, including an MMC (mixed-mode chromatography) step and how it allowed our client Igyxos Biotherapeutics to simplify and accelerate their clinical trial supply while achieving high-quality material.
Marie Cecille
Merck
Technical Leader
Thierry Ziegler
Igyxos
Chief Operation Officer
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
CellPrime® rLR3 IGF-1 Optimizing Cell Culture Productivity
Use CellPrime® rLR3 to optimize your cell culture media formulations. We will present details on how supplementing media with Cellprime® rLR3 IGF-I alone, or in combination with insulin, can speed growth as well as increase viable cell density and protein production.
Dennis Binder
Merck
Head of QC Cell Culture Media
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
How to Leverage the ICH Q5A Guidance to Implement the Next Generation of QC Testing
ICH Q5A revision encourages the use of NGS and PCR-based tests to detect viral contamination. Learn about strategies for implementation of these at different steps of the manufacturing process and the requirements for regulatory acceptance.
Manjula Aysola, Ph.D.
Merck
Senior Regulatory Consultant
Pharma and biopharma manufacturing, Downstream Processing
The Use of Meglumine Within the Developability Classification System and Beyond
Poor solubility is a key challenge in todays’ formulation development. Tune in to our webinar to discover how the Developability Classification System (DCS) and Meglumine can support you with these challenges and more.
Erik Peiter
Merck
Strategic Marketing Manager – Excipients Solid Application
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Monitoring and Quality Control of Cell Culture Media Preparation using Raman Spectroscopy
Cell culture media is one of the main components of a process, but the quality of its preparation is poorly monitored due to the lack of effective methods. We will explore the uses and benefits of Raman spectroscopy for monitoring media preparation and the possibilities of identifying sources of error that could impact cell culture.
Nathan Gay
Merck
Bioprocess Applications Engineer
Pharma and biopharma manufacturing, Downstream Processing
How Will ICH Q5A(R2) Affect the Design of Virus Clearance Studies?
Are you aware of the new draft ICH Q5A (R2) and the updated regulations? In this talk, we will discuss new recommendations for virus clearance studies of continuous manufacturing and gene therapy vectors. Learn more about the impact on your projects before the draft is finalized in 2023.
Steven McDade
Merck
Associate Director, Sales Development, APAC
Pharma and biopharma manufacturing, Downstream Processing
How Updates to EU GMP Annex 1 Impact Sterilizing Filtration in Single Use Systems
Recent revisions to EU GMP Annex 1 mean drug manufacturers may need to reassess sterile filtration in single-use systems. Learn how suppliers are designing smarter to meet updated regulatory expectations.
Simone Biel, Ph.D.
Merck
Senior Regulatory Consultant
Monica Cardona
Merck
Senior Program Manager
Lauren Kacmarcik
Merck
Product Manager, Final Filtration
Protein biology, ELISA
Detection is Critical: Designing Immunoassays with Guidance in Mind
This webinar will detail each of these steps with data from our Conferma® ELISA development and QC processes, describe its impact on their performance and discuss if this could become a broadly accepted practice.
Lawrence Rentoul
Merck
Portfolio Lead, ELISAs & Specialty Assays
Materials science and engineering, Nanoparticle and microparticle synthesis
Self-Assembly and Study of Single Nanoparticles and Molecules
Prof. Kasper Moth-Poulsen
Merck
Ph.D., ICREA prof. at the Institute of Materials Science of Barcelona
Microbiological testing, Bioburden testing
Bioburden and the new EU GMP Annex 1: Risk Assessment, Reduction, and Testing
Join our panel discussion on January 18, 2023, where experts on regulation, filtration, sampling and quality control will share insights on how to overcome these challenges and ensure a successful bioburden reduction and testing, in compliance with the new EU GMP Annex 1 regulation coming into operation on August 25th, 2023.
Adrien Venchiarutti
Merck
Global Product Manager–Filtration & Rapid Detection Platforms
Marilyn Romieux
Merck
Director of Strategic Marketing Pharma
Marc-Antoine Kaag
Merck
Global Product Manager Sampling
Stéphanie Huck
Merck
Lead Application Services, Biomonitoring
Simone Biel, Ph.D.
Merck
Senior Regulatory Consultant
Somasundaram G (Som)
Merck
Senior Consultant
Pharma and biopharma manufacturing, Downstream Processing
Vaccine Journey: Bench to Market
In this webinar, you will hear from all key opinion leaders in the field, explaining a fascinating story behind the scene for COVID-Vaccine development.
Josephine Cheng
Merck
Senior Consultant, Core Modalities Asia Pacific, Bioprocessing Strategy
Subhasis Banerjee, Ph.D.
Merck
Principal Bioprocessing Application Expert
Dr. Ravi Ganapathy
Hilleman Laboratories Singapore Pte Ltd
Director, CMC R&D
Maria Elena Bottazzi
Baylor College of Medicine
Co-Director
Dea Marsendah
Biofarma
Head of Development Management Department
Bin Wang
Merck
Director of Technical & Scientific Solutions Group
Microbiological testing, Sterility testing
EU GMP Annex 1 (Draft 2020) and How it Affects Aseptic Manufacturing
Dr. Anne-Grit Klees
Merck
Global Product Manager Environmental Monitoring
Aram Montazami
BEng, Vice President of R&D – Cofounder
Novatek International
Pharma and biopharma manufacturing, Liquid Formulation Strategies
Custom LNP Formulation Development - The New Early Formulation Screening Service as a Key Partner for Success
Nucleic acid-based therapies hold great promises to revolutionize medicine. This webinar will introduce our new Early Formulation Screening service, dedicated to formulation development of RNA-loaded lipid nanoparticles, and will highlight our capabilities within our integrated CDMO offering.
Johanna Simon, Ph.D.
Merck
Principial Scientist
Pharma and biopharma manufacturing, Monoclonal antibody manufacturing
Characterization of Monoclonal Antibodies and Antibody Drug Conjugates by Surface Plasmon Resonance
Characterization of therapeutic monoclonal antibodies (mAbs) or Antibody drug conjugates (ADCs) is challenging due to their ability to bind to a variety of proteins via their Fc and Fab domains, giving rise to diverse biological functions associated with each domain. The Fc domain of mAbs interacts with Fc receptors with varying affinities, which can influence biological processes such as Complement-dependent cytotoxicity (CDC) and Antibody-dependent cellular cytotoxicity (ADCC), transcytosis, phagocytosis, and/or serum half-life.
Helen Hsu, Ph.D.
Merck
Principal Scientist, Process and Analytical Development
Environmental and cannabis testing, Waste water and process water testing
Addressing the Challenges of PFAS Analysis in a Variety of Matrices: From Air to Zipper Bags
The analytical challenges and approaches associated with the diverse matrices currently studied in the analytical laboratory, focusing on particular problems and solutions to yield the most confidence in your testing results.
Andrew Patterson
Eurofins Environment Testing America
Corporate Technical Director, Specialty Services
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Collaboration to Develop Modular Facility Proof-of-Concept for Multi-Modal Bioprocessing Activities
This webinar describes the collaboration of our company and G-Con to develop a proof-of-concept facility design that enables multi-modal bioprocessing, including our process equipment, with greater flexibility and agility and facilitates tech transfer and future expansion. Details about the design, timelines, and costs will be included.
Jérome Dalin
Merck
Senior Consultant - EMEA Traditional Modalities, Bioprocessing Strategy Operationalization
Thomas Hauser
G-CON Manufacturing
Business Development Manager EMEA
Pharma and biopharma manufacturing, Downstream Processing
Closed Concept for Biopharmaceutical Manufacturing
Biomanufacturing faces increasing pressure to be more responsive to market demands. As such, the industry has focused on process intensification to enhance efficiencies while ensuring product quality. How does being closed processing ready enable this, and how can it be achieved?
Ashok Kumar
Merck
Head of Single-Use and Integrated Systems, India
Somasundaram G (Som)
Merck
Senior Consultant
Analytical chemistry, Calibration, qualification, and validation
Substitution of Hazardous Substances
Take a deep dive into identifying hazardous substances, risk assessment, how mistakes can be avoided, and what to do if no substitution is possible. Learn how to conduct a legally compliant substitution check using real substances as examples.
Dr. Birgit Stöffler
Merck
Safety Specialist
Materials science and engineering, Organic electronics
Production of valuable fine chemicals and renewable energy through Metal-Organic Frameworks (MOFs)-Assisted Catalysis and Membrane Separation
In this webinar, learn about MOFs which are used as effective catalysts for producing (1) several valuable fine chemicals such as FDCA and DMF from lignocellulose biomass waste and (2) hydrogen gas from waste plastics.
Kevin C.-W. Wu
National Taiwan University
Professor
Pharma and biopharma manufacturing, Liquid Formulation Strategies
How to Improve API Solubility by Salt and Cocrystal Formation
Many APIs are not being commercialized as they are poorly water soluble, thus exhibiting too low bioavailability. Salt and cocrystal formation can be means to improve drug solubility, but also stability and processability. Learn how to identify suitable coformers - and how to avoid obstacles.
Thomas Briel, Ph.D.
Merck
Strategic Marketing Manager, Excipients Liquid Application
David Luedeker, Ph.D.
Merck
Principal Scientist - Solid Formulation
Microbiological testing, Microbial culture media preparation
Ensure Validity of your Halal Certification with Suitable Culture Media
The global market of halal products is estimated at 2.3 trillion US dollars annually and is expected to grow steadily over the next years. Halal certification of products states that the manufacturing facility complies with halal regulations during manufacturing or processing. However, new regulations in some Islamic countries point to the risk of microbiological culture media carrying hidden non-halal materials into production areas, thus compromising the halal certification status.
Andreas Bubert, PhD
Merck
Senior Product Manager, Culture Media Food & Beverage
Pharma and biopharma manufacturing, Downstream Processing
Integration of On-line HPLC as a PAT Tool for CQA Monitoring and Control in Bioprocessing
Looking to expedite your access to critical process parameters (CPP) and critical quality attributes (CQA) in bioprocessing? Join this webinar to learn how on-line HPLC can be implemented as a Process Analytical Technology tool to expedite access to CPP/CQA information that can be used to implement advanced process control.
Stacy Shollenberger
Merck
Senior Marketing Manager, Process Analytical Technologies
Daniel Kutscher, Ph.D.
Agilent Technologies
Product Manager, Strategic Marketing
Pharma and biopharma manufacturing, Solid Formulation Strategies
Formulation and Predictive Technologies to De-Risk Solid-State Variation in Drug Development
Variability in polymorphism and powder properties can lead to risks in every stage of the drug development process. By combining formulation tools with crystal structure prediction, this risk can be minimized - improving cost and efficiency in the development of oral dosage forms.
Gudrun Birk, Ph.D.
Merck
Head of Controlled Release
Michael Belucci
XtalPi
Senior Director - Solid Form Design
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Going Viral: Process and Facility Design Considerations for CGT Manufacturing
Manufacturing of CGTs is complex: multiple facilities, multiple processes and complex logistics. Can existing capabilities in other biologics be leveraged to overcome this? How do strategic considerations e.g. buy/make choices influence your chances to successfully bring CGTs from clinic to commercial?
David Loong, Ph.D.
Merck
Senior Consultant, Novel Modalities Asia Pacific, Bioprocessing Strategy
Ina Bhartia
Merck
Senior Strategy Manager
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
3rd Annual Biotech Start-up Symposium
We invite you to the Third Annual Biotech Start-up Symposium, a free, three-day event to help Biotechs Start-ups navigate their path to commercialization. This Symposium will feature industry experts who will present and discuss various aspects of emerging technologies and the latest trends in their fields.
Steven Richardson
Merck
Technology Consultant, Upstream Bioprocessing
Kaelyn Wilke
Merck
Associate Director, ADC & Bioconjugation Services
Jean François Michel
Merck
Head of Commercial Manufacturing, Biologics CDMO
Jean-Baptiste Noirot-Cosson
Merck
Head of Manufacturing Science and Technology, Biologics CDMO
Ratish Krishnan
Merck
Senior Strategy Consultant
Kate Achtien
Merck
Program Manager, BeyondCHO Products and Innovations
Katie Schewe
Merck
Product Manager, Upstream Bioprocessing
Antoine Heron, Ph.D.
Merck
Principal Consultant, Cell Therapy & Novel Modalities Merck KGaA, Darmstadt, Germany
Danielle DiTirro, Ph.D.
Merck
Technical Specialist, BioReliance® Services
Anique ter Braake, Ph.D.
Merck
Biotechnology Associate Analyst, M Ventures
Loic Sebileau
Leon Berard Comprehensive Cancer Center (CLB) & Cancer Research Center of Lyon
Technology Transfer Officer & Industrial Partnership Manager
Nathalie Donne
ErVaccine Technologies
Co-CEO
Dirk Lange
Merck
Global Head Life Science Services
Manuel Kretschmer
Merck
Head of Strategy, BioProcessing
Jolly Mazumdar
Chimeron
Founding CEO
Peter van de Sande
Synaffix
CEO
Jérémie Laurent
Merck
Founding CEO
Protein biology, Clinical testing and diagnostics manufacturing
Contract Antibody Development
In this webinar, you will learn about manufacturing, purification and cell banking of antibodies.
Michael Moehlenbrock, Ph.D.
Merck
Business Development Manager - Diagnostic Immunoassays
Sinead McManus
Merck
R&D Manager
Jennifer McGrath
Merck
R&D Scientist
Analytical chemistry, Sample preparation
BioSPME: A Novel Sample Preparation of Clinically Relevant Analytes
M. James Ross
Merck
Senior Scientist
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Utilization of Automated Aseptic Sampling for Accelerated Access to Process and Quality Data in Upstream Bioprocessing
The Biopharmaceutical industry is shifting from processes with manual operations to automated workflows, enabling improved product quality and real-time batch release in production facilities as well as faster decision making in the development phases.
Allyson Caron
Merck
R&D Manager, Upstream Bioprocessing Applications
Environmental and cannabis testing, Waste water and process water testing
Photometric Water Testing - A Solution for Every Step of the Analysis
Treatment of wastewater and process water is necessary to preserve public health and the environment. Regular analytical testing at various treatment steps is required by most regulatory bodies. Both instrumentation and consumables quality are crucial to ensure reliable and robust test performances.
Dr. Johanna Tornatzky
Merck
Global Product Manager for Spectrophotometry Consumables
Andrea Santiago
Merck
Global Product Manager for Photometry Workflow - Instruments
Analytical chemistry, Titration and Karl Fischer titration
Titration: Fulfil Pharma Regulatory Requirements and Optimize Your Workflows
Generating transparent and correct analytical results is imperative to ensure high quality in the pharmaceutical final products. Attend this webinar to broaden your knowledge on why it is important to understand influences on titration processes. You will also learn how to advance your titration process using new technologies to ensure data integrity, to meet quality assurance aspects and to comply with regulations.
Bettina Straub-Jubb
Merck
Global Product Manager, Karl Fischer Titration
Thomas Hitz
METTLER TOLEDO
Application Chemist
Pharma and biopharma manufacturing, Viral Vector Upstream Processing
Flexible, Simplified, and Scalable Solutions for AAV Viral Vector Production
AAV upstream processes need to be scalable and high titer to meet the increasing demand needs of gene therapies. Previous processes based on adherent culture will not be suitable for high-dose indications. We present two suspension-based upstream production platforms with data for AAV production.
David Loong, Ph.D.
Merck
Senior Consultant, Novel Modalities Asia Pacific, Bioprocessing Strategy
Rain Lee
Merck
Upstream Technical Application Expert, SEATW & Oceania
Pharma and biopharma manufacturing, Liquid Formulation Strategies
How to Select Optimum Preservatives for Liquid Formulation
Did you know? The four major preservatives already make up 71% of marketed products. And one of those should not be used in neonates! This, and more things to consider when selecting the right preservative for your liquid formulation.
Smita Rajput, Ph.D.
Merck
Field Marketing Manager
Prateek Garg
Merck
Global Segment Marketing Manager, Small Molecules
Materials science and engineering, Batteries, supercapacitors, and fuel cells
Designing Nanomaterials for Battery, Fuel Cell, and Electrolyzer
This webinar will touch on electrocatalysts, electrodes, and devices for battery, fuel cell and water electrolyzer. The presentation will focus on material design, nanoparticle synthesis, nano- and microstructure fabrication, and electrochemical evaluation.
Professor Yung-Eun Sung
Seoul National University
Professor
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Integration of Raman Spectroscopy for In-line and Real-time Monitoring of Critical Process Parameters and Quality Attributes in CHO Cell Perfusion Cultivation Modes
In this webinar, we will explore the use and benefits of Raman spectroscopy for monitoring bench-scale CHO cell intensified seed trains (N-1), steady state and dynamic perfusion (N) cultures. And also discover the value of combining automated sampling with Raman spectroscopy for increased sample frequency.
Rakesh Bobbala
Merck
Applications Engineer
Analytical chemistry, Large molecule HPLC
Strategies for Efficient Analyses of Proteins: From Aggregates to Post-Translational Modifications
This seminar will focus on strategies and techniques to maximize efficiency and resolution when using reversed phase chromatography (RPC) and size exclusion chromatography (SEC) in analyzing biomacromolecules. The attendees will learn how to select and the importance of phase chemistry and particle morphology in analyzing biomolecules and discover best practices in choosing appropriate mobile phase systems for each mode of chromatography.
Andrea Krumm
Tosoh Bioscience GmbH
Product Manager, Analytical Columns
Cory E. Muraco
Merck
Biomolecule Workflows Manager
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
A Rapid, Innovative Approach to Release Testing with Blazar® CHO AOF Virus Panel
Innovative molecular methods will allow mAbs manufacturers to deliver critical therapeutic agents to patients faster. The Blazar® CHO AOF virus panel is a powerful tool to accelerate bulk harvest testing with the potential to replace slower culture-based in vitro virus detection methods.
Mohammad Heydarian, Ph.D.
Merck
Principal Scientist
Pharma and biopharma manufacturing, Viral Vector Upstream Processing
Driving the Viral Vector Expressway: Speeding Through AAV Manufacturing
The production of AAV viral vectors for gene therapy comes with unique upstream challenges. Learn how our HEK platform can solve these challenges.
Henry George
Merck
Head of R&D for Viral Vector Producer Cell Lines
Andi Ushijima
Merck
Scientist, Viral Vector Technology and Innovation
Protein biology, Clinical testing and diagnostics manufacturing
Recombinant Antibodies for Research and Diagnostic Assay Manufacturing
In this webinar, the speakers will summarize the reverse engineering of critical IVD-IHC antibodies, and novel active and passive blocking products derived through novel B-cell cloning methods. These methods aim at sustainability and consistency, thereby reducing the impact on animal hosts.
Sean Roenspie
Merck
Senior Research Scientist - Antibody Discovery Group
Juliet Rashidian, Ph.D.
Merck
Senior Research Scientist - Antibody Discovery Group
Michael Moehlenbrock, Ph.D.
Merck
Business Development Manager - Diagnostic Immunoassays
Analytical chemistry, Low pressure liquid chromatography
Webinar: A Full Overview of Different Technologies to Increase HPLC Efficiency & Speed
This webinar provides an overview on the factors that influence the speed of the HPLC method. It introduces the different approaches of smaller HPLC particles, Fused-Core® (also known as core-shell) particle technology and monolithic silica rods and discusses the advantages and disadvantages of each approach. The presentation covers the theoretical background of these technologies and multiple examples of applications.
Dr. Frank Michel
Merck KGaA, Darmstadt, Germany
Analytical & Chromatography Scientific Advisor
Pharma and biopharma manufacturing, Biotech Resource Hub
The Art Of The Possible: Reimagining The Biopharmaceutical Supply Chain
Programmed by Economist Impact and sponsored by {hcompnay}, we will examine what leaders in the biopharmaceutical supply chain must do to steer their businesses through a time of rapid change and ongoing disruption, and identify synergies and efficiencies to bring drugs to market more effectively.
Meeta Gulyani
Life Science MilliporeSigma
Head of Strategy, Business Development and Sustainability
Mike Douma
AbbVie
Vice President, Supply Chain
Tacy Foster
McKinsey
Partner
Anne McDonald Pritchett
PhRMA
Senior Vice President, Policy and Research
Alan Lovell
Economist Impact
Senior Manager, Health, Policy and Insights
Analytical chemistry, Low pressure liquid chromatography
Reflecting on Chiral: Strategies and Tools for Efficient Enantiomer Separations
The focus of this seminar is to provide an overview of different strategies and methods employed over the past several years in characterizing samples containing chiral compounds.
Cory E. Muraco
Merck
Biomolecule Workflows Manager
Dr. Paul Rodwell
Merck
Senior Technical Advisor, Liquid Chromatography
Chemistry and synthesis, Synthetic methods
Cyrene™ Solvent, Cyrene™ Blends and Levoglucosenone Applications in Organic Synthesis
This talk will highlight the use of Cyrene™ solvent as a greener alternative to Dimethylformamide (DMF) and N-Methyl-2-pyrrolidone (NMP).
Dr. Jane Murray
Merck
Global Head of Green Chemistry
Pharma and biopharma manufacturing, Viral Vector Upstream Processing
Get the Most out of Your Fed-batch Process with Cellvento® ModiFeed Prime COMP
The biopharmaceutical industry continues to seek new efficiencies through higher-titer fed-batch production process developments, which require innovations in media combinations, feeding options, and screening strategies to meet the high and complex nutrient demands for growth in fed-batch operations.
Rain Lee
Merck
Upstream Technical Application Expert, SEATW & Oceania
Analytical chemistry, Photometry and reflectometry
Digital In-process Analyses Solutions to Solve Increased Testing Needs
Get accurate test results with your handheld instrument or smartphone.
Saskia Neubacher, Ph.D.
Merck
Global Product Manager for Rapid Chemical Testing
Pharma and biopharma manufacturing, Downstream Processing
Effective Implementation of Multi-Column Chromatography
Multi-column chromatography is a bioprocessing technique where multiple columns are loaded in series and then cycled. The systems required to manage such a process have a distinct set of requirements over and above a standard chromatography system.
Paul Beckett
Merck
Senior Manager, Downstream Technologies, BioContinuum™ Platform
Microbiological testing, Viable air monitoring
Microbial Sampling of Compressed Gases Has Never Been So Simple and Safe: Let’s Talk About the MAS-100 Atmos®!
In this webinar, Sabine Bessières Recasens will present the key features of the innovative MAS-100 Atmos® system, designed for the user peace of mind, ease of use, maximum safety and full regulatory compliance.
Sabine Bessières Recasens
Merck
Western Europe Field Marketing Manager, BioMonitoring
Pharma and biopharma manufacturing, Classical pharma manufacturing
Overcoming Challenges in Ophthalmic Formulations with Right Quality of Excipients
This webinar will address how to overcome common challenges in ophthalmic formulations with selection of right quality of excipients.
Smita Rajput, Ph.D.
Merck
Field Marketing Manager
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Advance your titration process – ensure data integrity and correct results
Separation Science, in collaboration with the life science business of Merck and Mettler-Toledo, offers a webinar that will help you gain a better understanding of how to advance your titration process using new technologies to ensure data integrity and to meet quality assurance aspects.
Bettina Straub-Jubb
Merck
Global Product Manager, Karl Fischer Titration
Thomas Hitz
METTLER TOLEDO
Application Chemist
Food and beverage testing and manufacturing, Chemistry and synthesis
Green Chemistry: Replacing Hazardous Solvents & Creating Value from "Waste"
Professor Cameron Weber
Senior Lecturer, University of Auckland
BSc(Adv)(Hons) and PhD, University of Sydney,
Professor Tony (Antonio) Patti,
Professor, School of Chemistry, Monash University
BSc (Hons) PhD (Chemistry), University of Melbourne, Grad Dip in Education (ACU),
Pharma and biopharma manufacturing, Viral Vector Upstream Processing
Cold Hard Facts: Implementing High Cell Density Cryopreservation in Your Intensified Seed Train
Explore the use and benefits of a high cell density cryopreservation (HCDC) method that utilizes bag assemblies specifically designed for freezing cells at higher densities and larger volumes. Get more insights about the integration of a perfused N-1 step in upstream process.
Chris Kornfeld
Merck
Technical Consultant, Upstream Manufacturing Sciences and Technology
Environmental and cannabis testing, Waste water and process water testing
Critical considerations when choosing a syringe filter for HPLC, UHPLC, and LC-MS/MS analysis. A case study with PFAS Analysis
We cover the most important factors to consider while choosing a filter membrane, including membrane material, to chemical compatibility, extractables and particle retention. Then, a case study is provided for choosing the right syringe filter device for sample preparation in the analysis of different per- and polyfluoroalkyl substances (PFAS) in water samples.
Lindsay D. Lozeau, PhD
Merck
Research Scientist Analytical Sciences
Protein biology, Protein quantitation
Detecting Low-Abundant Neurofilament Light Chain
Rick Wiese
Merck
Head of Singleplex & Special Protein Platforms R&D
Chemistry and synthesis, Lead discovery
Novel Reactivity in Hypervalent Iodine-Mediated Arylations and Vinylations
Novel methodology will be presented, where diaryliodonium salts and vinylbenziodoxolones are utilized for diarylations and selective vinylations under mild and transition metal-free conditions.
Berit Olofsson
Stockholm University, Sweden
Dean of Chemistry
Analytical chemistry, Environmental and cannabis testing
Analytical Quality Assurance for accurate water analysis with photometry
The analytical quality assurance is one of the most important steps to assure the quality of the measured results. Photometric methods are used in many laboratories for the examination of water and wastewater samples.
Gunter Decker
Merck
Senior Manager, Subject Matter Expert Point-of-Use Analytics
Pharma and biopharma manufacturing, Gene therapy manufacturing
Moving your Gene Therapy from R&D to IND: How to Navigate the Regulatory Landscape
In this webinar, we will address regulatory guidelines, when to start implementing GMPs and validated assays, getting QC testing strategy right, and tesing.
Alison Armstrong, Ph.D.
Merck
Sr. Director, Technical and Scientific Solutions
Manjula Aysola, Ph.D.
Merck
Senior Regulatory Consultant
Analytical chemistry, Gas chromatography
Best Practices for Collecting Air Samples using Thermal Desorption Tubes
In this webinar we’ll walk you through the steps on how to properly capture air samples using thermal desorption tubes.
Jamie Brown
Supelco Inc
Senior R&D Scientist
Pharma and biopharma manufacturing, Solid Formulation Strategies
Discover Excipients to Stabilize your Biomolecule Formulation Using a Surfactant
Biotherapeutic proteins experience various destabilizing conditions during manufacturing, transportation and storage. In this webinar, we will discuss the addition of surfactants as part of a robust and stable formulation to stabilize proteins and ensure the desired therapeutic activity and safety of biologics.
Nelli Erwin, Ph.D.
Merck
Senior Manager, Head of Protein Stability
Chemistry and synthesis, Lead discovery
A New Screening Approach for Lead Discovery: DNA-Encoded Library Technology
This webinar covers a new approach to lead discovery and screening compounds, presented in partnership with DyNabind. Watch to learn more about our DNA-encoded library technology.
Mike Thompson
Dynabind
CEO
Francesco Reddavide
Dynabind
Director of R&D
John Fetter Ph.D
Merck
Product Manager, Emerging Chemical Synthesis
Pharma and biopharma manufacturing, Solid Formulation Strategies
Key Considerations for the Development of Lipid Nanoparticles for RNA Delivery
With the growing development of lipid nanoparticle formulations for RNA delivery, there are a few key considerations for the lipids excipients used that are critical for success. This webinar will give you a snapshot of these as well as an overview on lipid quality particularly.
Estelle Beguin, Ph.D.
Merck
Strategic Marketing Manager - Synthetic Lipids
Chemistry and synthesis, Lead discovery
Joint Symposium on Chemistry Frontiers: Chemical Science Hot Articles In Organic Synthesis
This is a joint symposium between Royal Society of Chemistry (RSC) and Merck KGaA, Darmstadt, Germany. Together, we will feature some hot articles in Organic Synthesis from Chemical Science, the flagship journal of RSC.
Prof. Xiaoming Feng, Ph.D.
Sichuan University, China
Academician of the Chinese Academy of Sciences
Prof. Ning Jiao, Ph.D.
Peking University, China
Associate Editor of Chemical Science
Prof. Yizhou Li, Ph.D.
Chongqing University, China
Clinical testing and diagnostics manufacturing, IVD manufacturing
@ the lab bench v-log series
Diagnostic assay developers now have their own video series! Join us @The Lab Bench where IVD developers discuss assay tech challenges.
Matthew Coussens
Merck
Ph.D., Product Training Manager
Environmental and cannabis testing, Cannabinoid Profiling and Potency Testing
Cannabinoids Analysis of Hemp Derived Products- Developing Methods That are Robust and Dependable
In this webinar, simple and accurate sample preparation methods developed for the reliable HPLC-based analysis of cannabinoids from several matrices will be discussed.
Sunil P Badal, Ph.D.
Merck
Senior Scientist, Reference Materials & Workflows R&D
Pharma and biopharma manufacturing, Gene therapy manufacturing
Identity Testing by NGS as a Means of Risk Mitigation for Viral Gene Therapies
In this webinar, we will discuss appropriate risk mitigation testing strategies for viral gene therapies.
Bradley Hasson
Merck
Director of Lab Operations for NGS Services
Pharma and biopharma manufacturing, Downstream Processing
Single-Use Systems – A Prerequisite for Closed Processing in Final Filtration and Filling Operation
We will focus on key considerations of SUS implementation in the light of expectations addressed in the upcoming European GMP Annex 1 on Manufacture of Sterile Products.
Simone Biel, Ph.D.
Merck
Senior Regulatory Consultant
Microbiological testing, Microbial culture media preparation
Set your Timer: A Proven Rapid Microbial Method Returns
Anke Hossfeld
Merck
Global Product Manager- Pharma Development
Estelle Zelter
Merck
Senior Product Manager–Pyrogens, Alternative & Rapid Sterility Testing
Adrien Venchiarutti
Merck
Global Product Manager–Filtration & Rapid Detection Platforms
Pharma and biopharma manufacturing, Solid Formulation Strategies
Latest Advancements of Melt-based 3D Printing Technologies for Oral Drug Delivery
In this webinar, you will learn the latest advancements of melt-based 3D printing approaches, application examples for the individual technologies, deep dive in the MED® 3D printing technology to design dedicated drug release profiles, and excipient requirements for 3D printing technology
Thomas Kipping, Ph.D.
Merck
Head of Drug Carriers
Xianghao Zuo, Ph.D.
Triastek, Inc.
Deputy Director of R&D
Chemistry and synthesis, Protein degradation
Targeted Protein Degradation and Drug Discovery
Mikihiko Naito, Ph.D.
Graduate School of Pharmaceutical Sciences, The University of Tokyo
Project Professor
Microbiological testing, Microbiological testing
Get your Aseptic Facility Ready for EU GMP Annex 1
The European Commission published a draft revision of Annex 1, on Manufacturing of Sterile Medicinal Products (1). One purpose of the revision was to introduce principles of Quality Risk Management (QRM) to allow the adoption of new technologies and innovative processes. The upcoming Annex 1 revision will include guidance specifically on designing a risk-based and effective contamination control strategy (CCS) based on a scientific assessment to understand the process and to apply risk management principles.
Sabine Bessières Recasens
Merck
Western Europe Field Marketing Manager, BioMonitoring
Anne Grit Klees
Merck
Global Product Manager Environmental Monitoring
Benoît Ramond
Sanofi Group
Head of Microbiology and Sterile Technology Expertise
Andrea Conti
Aspen, Normandy, France
Senior Expert on Microbiology, part of the Centre of Excellence for Sterile
Audrey Schultz
Delpharm, Saint Rémy sur Avre, France
Expert on Microbiology, Sterility Quality Assurance Department
Louisa Patterson
Merck
Head of Field Marketing and Validation Services, BioMonitoring
Pharma and biopharma manufacturing, mRNA
Balancing Risk, Speed, and Cost in Biopharmaceutical Process Development & Manufacturing
CDMO experts discuss implementing a successful biopharmaceutical process development and manufacturing strategy.
Abigail Guce-Merriam, Ph.D.
Merck
Manager, Downstream Process Development
Joshua Arias
Merck
Technical Lead, CDMO Services
Protein biology, Protein quantitation
Immunoassay Verification and Quality Control Practices and How They Affect Data Outputs
Discover how the quality and consistency of MILLIPLEX®️ multiplex assays enhance research by achieving consistent sample measurement and standard curve reproducibility.
Geoffrey J. Solares, Ph.D.
Merck
Immunoassay Field Application Scientist, Southwest Region
Pharma and biopharma manufacturing, Cell Line Development
Quality Improvement in Implemented Cell Line Development Process Based on the CHOZN-GS System
In this webinar, we discuss how, in the cell line development stage, we recently used the CHOZN-GS system to apply our quality-driven Fc-fusion protein screening procedures to select appropriate clones that ranged in the target product quality.
Dr. Young Min Oh
GI Innovation
Managing Director
Protein biology, ELISA
Advances in Immunoassays: SMC® (Single Molecular Counting) and Multiplexing
In this webinar, learn about the applications of multiplex assay kit over single ELISA kit for the quantification of immunopathological mediators from allergic mouse lung.
Winston Liao, Ph.D.
National University of Singapore - Yong Loo Lin School of Medicine
Senior Research Fellow, Department of Pharmacology
Anitaben Tailor, Ph.D.
Merck
Biology Technical Marketing
Pharma and biopharma manufacturing, Biologics and Biosimilars Characterization
Viral Safety of Biologics: What's Changing with the ICH Q5A Revision?
In this webinar, we discuss how the ICH Q5A revision impacts viral safety strategies for biologics, including virus testing, the regulatory landscape, and the impact on viral clearance.
Alison Armstrong, Ph.D.
Merck
Sr. Director, Technical and Scientific Solutions
Manjula Aysola, Ph.D.
Merck
Senior Regulatory Consultant
Pharma and biopharma manufacturing, Antibody drug conjugate manufacturing
Chasing the Nanogram Limit
In this webinar, we discuss the evolution of the high potent API manufacturing industry from 10 µg to single nanogram limits, safety concepts, and how we have met challenges and prepare to move forward.
John Stevens
Merck
Field Marketing Senior Specialist, Actives & Formulation
Analytical chemistry, Gas chromatography
Top Tips You Need to Know About Pharma QC Testing & Applications
This webinar will touch on the top key applications according to pharmacopoeia requirements that every Pharma QC lab runs.
Dr. Sanjay Poman
Merck Life Science Pvt Ltd, Mumbai, India, an affiliate of Merck KGaA, Darmstadt, Germany
Application Scientist
Dr. Frank Michel
Merck KGaA, Darmstadt, Germany
Analytical & Chromatography Scientific Advisor
Dr. Arnab Roy
Merck Life Science Pvt Ltd, Bangalore, India, an affiliate of Merck KGaA, Darmstadt, Germany
Global Product Manager, Reference Materials
Pharma and biopharma manufacturing, Liquid Formulation Strategies
Overcoming Viscosity Challenges in High Concentration Tangential Flow Filtration (TFF)
In this webinar, we will introduce the benefit of excipient combinations to reduce viscosity in tangential flow filtration (TFF) as well as the impact of a suitable cassette design to overcome these limitations.
Tobias Rosenkranz, Ph.D.
Merck
Senior Manager, Biomolecule Formulation R&D
Gerd Walter
Merck
Director, Customer Application, Downstream, EMEA
Pharma and biopharma manufacturing, Vaccine manufacturing
Insights From a Global Collaboration Accelerating Vaccine Development With an Optimized VLP Platform
Get insights and best practices from a multinational team establishing a platform for vaccine production. See how a long-term collaboration on a bench-scale process used to produce a Virus Like Particle (VLP) vaccine for SARS-CoV-2 was successfully converted to a robust GMP-compatible, scalable process.
Jose M. Galarza, PhD
TechnoVax
President and Founder
Naomi Baer
Merck
Business Development Consultant
Youssef Gaabouri, Eng.
Merck
Associate Director, Head of Sales Middle East & Africa
Clinical testing and diagnostics manufacturing, IVD manufacturing
Adaptive Learning Course: Rapid Point of Care Test Development
Michael Mansfield, Ph.D.
Merck
Applications Development Scientist
Pharma and biopharma manufacturing, Classical pharma manufacturing
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
In this webinar, we share a risk-based qualification testing strategy including extractables and data generated to support comparability of gamma irradiation and X-ray irradiation as equivalent ionizing irradiation sterilization methods.
Monica Cardona
Merck
Senior Program Manager
Paul Killian, Ph.D.
Merck
R&D Director, Analytical Technologies
Analytical chemistry, Titration and Karl Fischer titration
Improved Karl Fischer Titration Analyses & Regulatory Compliance
To have accurate, transparent, and comparable results, is key in our global environment and economy. Therefore, suitable working procedures and a reproducible and traceable documentation of results are high prerequisites.
Bettina Straub-Jubb
Merck
Global Product Manager, Karl Fischer Titration
Pharma and biopharma manufacturing, Gene therapy manufacturing
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot Release
Join this webinar to learn about a rapid RCA detection assay currently in development, which combines a 7-day culture assay with a highly sensitive molecular endpoint specific for RCA.
Alberto Santana, MBA
Merck
Product Manager, Biologics Biosafety Testing
Axel Fun, Ph.D.
Merck
Axel Fun, Ph.D.
Cell culture and analysis, Media preparation
Enter the New Era of Media Preparation with the ReadyStream® System
During this webinar, you will understand why we are saying that with our ReadyStream® system you will enter into a new era of media preparation. Ready to change the way you are making media?
Tim Cser
Merck
Sr. Technology Specialist
Markus Prengel
Merck
Global Product Manager, Sterility Testing
Pharma and biopharma manufacturing, Downstream Processing
EU GMP Annex 1 Draft — Closed System Design Consideration with Single-Use Systems
In this webinar, you will learn what are the EU GMP Annex 1 draft expectations on the use and control of single-use systems, which measures to take assuring the integrity of a single-use system, and how collaboration between supplier and end-user can support a risk-based contamination control strategy.
Simone Biel, Ph.D.
Merck
Senior Regulatory Consultant
Somasundaram G (Som)
Merck
Senior Consultant
Pharma and biopharma manufacturing, Solid Formulation Strategies
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to Ace the Patient's Taste Test
In this webinar, we present our toolbox of two high-performance sweeteners and focus on aspects of stability, safety, and application in various dosage forms as well as the market perception.
Almut von der Brelie
Merck
Senior Manager Strategic Marketing, Excipients for Solid Applications
Pharma and biopharma manufacturing, Classical pharma manufacturing
Aseptic Isolator Manufacturing: Introduction to Innovative Technology Solutions
Join us for this educational and interactive session which will conclude with a Q&A session with our experts.
Anne Connors
Merck
Senior Field Marketing Manager
Pharma and biopharma manufacturing, Antibody drug conjugate manufacturing
How to Accelerate and Enhance ADC Therapies
In this webinar, you will learn about the advantages of using advanced intermediates to develop ADC therapies, how to increase ADC solubility and efficiency, fast, small-scale ADC library generation, and seamless supply chain with reduced complexity and regulatory support
Ross Bemowski, Ph.D.
Merck
Associate Director of Analytical Development
Jeffery Carroll
Merck
Senior Scientist, Team Lead ADC Express, Process and Analytical Development
Pharma and biopharma manufacturing, Downstream Processing
Leveraging Traditional Chromatography Techniques for Downstream Purification of Novel Modalities
Learn how to implement chromatographic techniques using resin or membrane formats in your viral vector or pDNA processes.
Ratish Krishnan
Merck
Senior Strategy Consultant
Pharma and biopharma manufacturing, Viral Vector Upstream Processing
Introducing our Novel Sf9 Rhabdovirus-negative (Sf-RVN®) Platform
This webinar includes an introduction to insect cell expression systems, an overview of the Sf-RVN® Platform benefits, and a performance of the Sf-RVN® Platform for the production of recombinant proteins and AAV.
Charlotte Javalet, Ph.D.
Merck
Product Manager
Pharma and biopharma manufacturing, Plasma manufacturing
Elemental Analysis: Considerations for Trace Levels by AAS, ICP and IC
This webinar covers an overview of elemental analysis and trace levels considerations for AAS (Atomic Adsorption Spectrometry), ICP (Inductively Coupled Plasma), and ICP-MS (ICP Mass Spectrometry) and selecting the best technique for your lab's needs.
Lee May May, Ph.D.
Merck
Principal Scientist R&D, APAC Laboratory,
Pharma and biopharma manufacturing, Downstream Processing
How a Helium Manufacturing Release Test Increases Integrity Assurance for Single-Use Assemblies
This webinar describes the development and validation of the helium integrity test and demonstrates how it can benefit critical single-use process steps.
Monica Cardona
Merck
Senior Program Manager
Chuck Raye
Merck
Product Manager, Final Fill Single Use Systems
Food and beverage testing and manufacturing, Regulatory compliance
Dietary Supplements and Nutraceuticals: How to Ensure an Efficient and Regulatory Compliant Quality Control
Dr. Dnyanesh "DV" Darshane
FOBE Solutions LLC, USA
Managing Director
Matthias Nold, Ph.D.
Merck
Product Manager, Analytical Standards
Pharma and biopharma manufacturing, Downstream Processing
Addressing Downstream Challenges with Complex Injectables
In this webinar, you will learn why downstream processing is critical and complicated, about the sterile filtration of liposomes, nanoparticles, and viscous formulations, and about filter validation aspects and where our approach is different.
Partha Banerjee
Merck
Senior Technology Consultant
Pharma and biopharma manufacturing, Downstream Processing
Effective and Efficient Design of a Downstream Purification Process for Plasmid DNA
This webinar describes a complete solution encompassing all downstream unit operations from harvest to bulk filtration and includes a comprehensive case study.
Nargisse El Hajjami, Ph.D. Eng.
Merck
Senior Consultant
Thomas Elich
Merck
Manager, MSAT Americas Purification Process Engineering
Laurens Vergauwen
Merck
Process Development Scientist
Analytical chemistry, Photometry and reflectometry
Water Contaminant – What and How to Test for Them
In support of International Water Week, this webinar will explain the different analytical techniques used for testing various parameters in water analysis.
Dr. Frank Michel
Merck KGaA, Darmstadt, Germany
Analytical & Chromatography Scientific Advisor
Gunter Decker
Merck
Senior Manager, Subject Matter Expert Point-of-Use Analytics
Pharma and biopharma manufacturing, Downstream Processing
Viral Clearance — Something Went Wrong, What do I do Now?
In this webinar, we discuss potential issues that can arise during viral clearance study design and execution and strategies to mitigate certain risks.
Kathryn Martin Remington, Ph.D.
Merck
Technical Consultant
Kate Smith
Merck
Kate Smith
Pharma and biopharma manufacturing, Solid Formulation Strategies
Hot Melt Extrusion in Motion: Hands-on Demonstrations and Final Dosage Forms
In this webinar, we take a look into a running hot melt extrusion process in our R&D labs located in Darmstadt, Germany in order to provide you with a hands-on experience of the process.
Daniel Treffer, Ph.D.
MeltPrep
Founder and CEO
Margarethe Richter, Ph.D.
Thermo Fisher Scientific
Pharma Application Specialist
Thomas Kipping, Ph.D.
Merck
Head of Drug Carriers
Pharma and biopharma manufacturing, Downstream Processing
Endotoxin Control and Clearance in Biomanufacturing
In this webinar, we will discuss the regulatory norms, strategies for prevention and removal of endotoxin to ensure that the final drug product is safe.
Somasundaram G (Som)
Merck
Senior Consultant
Subhasis Banerjee, Ph.D.
Merck
Principal Bioprocessing Application Expert
Pharma and biopharma manufacturing, Solid Formulation Strategies
Optimizing Your Hot Melt Extrusion Process: Polymer Screening, Formulation, and Process Development
This webinar focuses on providing you with insights on how you can optimize your hot melt extrusion process with novel screening tools as well as guidance on how to identify suitable process parameters.
Daniel Treffer, Ph.D.
MeltPrep
Founder and CEO
Margarethe Richter, Ph.D.
Thermo Fisher Scientific
Pharma Application Specialist
Thomas Kipping, Ph.D.
Merck
Head of Drug Carriers
Food and beverage testing and manufacturing, Microbiological analysis
Qualification of Aseptic Filling Lines for Beverage Industry
The webinar explains the principles of aseptic media fill qualifications, the handling of Linden Grain Medium in the qualifications, the usage of LGM and provides practical tips, e.g. for PH adjustments, for optimal sterility test results.
Andreas Bubert, PhD
Merck
Senior Product Manager, Culture Media Food & Beverage
Silvia Garulli, Ph.D.
Sidel, Parma, Italy
Microbiology & Aseptic Laboratories Manager
Pharma and biopharma manufacturing, Compendial Testing and Regulatory Guidance
Regulatory Talks: Finalization of USP <665>
In this regulatory talk, an expert panel with the principle scientific liaison from the US Pharmacopeia will clarify details on the first compendial general chapter, USP <665>, for plastic components and systems used in drug manufacturing, focusing on the shift to this new approach and the necessity to conduct previous compendial test methods.
Janmeet Anant, Ph.D.
Merck
Senior Regulatory Consultant
Monica Cardona
Merck
Senior Program Manager
Desmond Hunt, Ph.D.
United States Pharmacopeia (USP)
Principle Scientific Liaison
Pharma and biopharma manufacturing, Solid Formulation Strategies
Getting to Know Hot Melt Extrusion: How Does it Support Drug Development and Which Excipients are Needed?
In this webinar, you will learn about the general hot melt extrusion process, the equipment employed in this technology as well as the requirements for excipients and polymers to be used in this application.
Margarethe Richter, Ph.D.
Thermo Fisher Scientific
Pharma Application Specialist
Thomas Kipping, Ph.D.
Merck
Head of Drug Carriers
Pharma and biopharma manufacturing, Downstream Processing
Parvovirus Filtration Best Practices - 25 Years of Hands-on Experience
This webinar will help parvovirus filter users achieve optimized performance and trouble-free operation.
Paul Genest
Merck
Consulting Engineer
Pharma and biopharma manufacturing, Biologics and Biosimilars Characterization
Top Reasons to Outsource your Early Biologic Development and Manufacturing to a CDMO
In this webinar, we will share highlights from a global market research survey of small, mid-sized, and large biopharmaceutical companies on key reasons to outsource their early-stage pipeline to a CDMO.
Magali Toueille, Ph.D.
Merck
Downstream Process Development Manager
Celine Raymond, Ph.D.
Merck
Upstream Process Development Manager
Protein biology, Protein quantitation
Opportunities and challenges of blood-based biomarkers in Alzheimer's disease
Lei Liu, MD, PhD
Harvard Medical School
Assistant Professor of Neurology
Anitaben Tailor, Ph.D.
Merck
Biology Technical Marketing
Pharma and biopharma manufacturing, Downstream Processing
Get Proactive With Your Stability Program
Understanding how your mAb behaves under various conditions is a crucial part of product characterization and quality assurance programs. Join this panel-style webinar to gain insights into key aspects of stability testing, from regulatory expectations to timeline and design considerations.
Greg Pirozzi, Ph.D.
Merck
Senior Project Manager, Custom Projects
Pamela Hamill, Ph.D.
Merck
Technical Consultant, Field Technology Management
Pharma and biopharma manufacturing, Cell Line Development
Risk Mitigation in Cell Line Development: Regulatory Considerations and Impact on Quality Assurance
The choice of production cell line, culture conditions, and a chemically defined CLD process by using CD cloning media can impact the subsequent measures for the chemistry, manufacturing, and controls. In this presentation, we will discuss these choices and their impacts on subsequent bioprocess and CMC testing required by regulations and the benefits of incorporating CD cloning media into the CHOZN® expression platform.
Janice Tan, Ph.D.
Merck
Head of Upstream MSAT, APAC excluding China
Edmund Ang, Ph.D.
Merck
Senior Technical Specialist
Microbiological testing, Pharma and biopharma manufacturing
Recovery of Bacteria from Neoprene® Gloves and Stainless Steel
Tim Cser discusses our study proving the suitability of ICR swabs and contact plates to detect low numbers of several bacteria strains from Neoprene® gloves and stainless steel.
Tim Cser
Merck
Sr. Technology Specialist
Analytical chemistry, Low pressure liquid chromatography
How to Increase The Cost Effectiveness for HPLC Separations of Challenging and Matrix-rich Samples
Petra Lewits
Merck
Global Product Manager for Analytical Chromatography, HPLC columns
Pharma and biopharma manufacturing, Antibody drug conjugate manufacturing
Payload Core Product Line Accelerates ADC Clinical Timelines
Currently, innovators must endure years of development and manufacturing to arrive at the most commonly used cGMP payloads. In this webinar, we explore our payload core product line which can get developers to the clinic faster while reducing risk.
David Goeddel, Ph.D.
Merck
Director of API R&D
Pharma and biopharma manufacturing, Antibody drug conjugate manufacturing
ADC Production - A Journey Made Safer and Faster
The global ADC market is growing rapidly. The increasing number of cancer patients and the wider therapeutic windows are driving the growth in the number of ADC pipelines. In this webinar, we will explain how to simplify manufacturability of ADCs using Single-Use technology and innovative chemical platforms.
Ashok Kumar
Merck
Head of Single-Use and Integrated Systems, India
Giuseppe Camporeale, Ph.D.
Merck
Global Field Marketing Manager Actives
Analytical chemistry, Titration and Karl Fischer titration
Karl Fisher: Como extrair resultados na sua rotina analítica
Karl Fischer's analysis plays a fundamental role in the control of raw materials and finished products in the most diverse segments of industrial activity.
Aline Recacho
METTLER TOLEDO
Application Specialist
Diego Araujo
Merck
Analytical Workflow Product Specialist
Analytical chemistry, Titration and Karl Fischer titration
Continue to Improve your Titration Process with New Tips and Tricks with Special Focus on Food & Beverage Applications
Titration is a common method to deermine the composition of food and beverages in order to ensure quality and taste. Learn how to optimize the process and how to prevent failures and uncertainties in the results.
Bettina Straub-Jubb
Merck
Global Product Manager, Karl Fischer Titration
Research and disease areas, Metabolism research
Metabolomic Links Between Environmental Exposures and Human Health
Lauren Petrick, PhD
Icahn School of Medicine, Mount Sinai Health System
Associate Professor
Vrinda Kalia, MPH, PhD
Mailman School of Public Health, Columbia University
Postdoctoral Research Scientist
Materials science and engineering, Contact lens and dental manufacturing
To Accelerate Your Medical Device Commercialization, You May Have to Think Outside Your Box
Cheri Drennan
Merck
Head of Strategic Implementation & Marketing, CMO
Robert Fyalka
Merck
Senior Commercial Project Manager
Pharma and biopharma manufacturing, Solid Formulation Strategies
Continuous Manufacturing: Issues and Answers
Continuous manufacturing is a major trend in solid dose formulation. It shows economic and quality benefits, however, hurdles and challenges need to be tackled before getting there. This webinar will address these hurdles and challenges as they relate to excipients.
Leo Ohrem
Merck
Strategic Marketing Manager
Protein biology, Protein quantitation
Measuring Beyond the Limitations of ELISAs
Discover why researchers are looking beyond ELISAs to detect the previously undetectable with an ultrasensitive biomarker detection platform that increases assay sensitivity by up to 1,000-fold.
Craig Lanio
Merck
Senior Scientific Sales Manager
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Arcofolin® - Why the Form of Folate Matters
In this webinar, learn how the form of folate, an essential B vitamin, matters in experiencing the next level of folate.
Rima Obeid, Ph.D.
Central Laboratory, Saarland University Hospital
Professor, Department of Clinical Chemistry and Laboratory Medicine
Jean-Pierre Knapp
Merck
Senior Scientist, Analytics Quality Services
Food and beverage testing and manufacturing, Regulatory compliance
Role of Food & Beverage Manufacturers in Ensuring Food Safety Compliance
Dr. Dnyanesh "DV" Darshane
FOBE Solutions LLC, USA
Managing Director
Pharma and biopharma manufacturing, Liquid Formulation Strategies
Regulatory Experience Sharing: Excipients for use in Lipid Nanoparticles
The use of excipients in lipid nanoparticles pose challenges to regulatory agencies concerning purity and safety assessment when predicting the in vivo performance of the formulation. In this webinar, we will provide an overview on the specific regulatory requirements and identify gaps in current regulations.
Claudia Widmann, Ph.D.
Merck
Regulatory Expert
Analytical chemistry, Titration and Karl Fischer titration
Volumetric Titration: A Step-by-Step Guide to Correct Results
Angela Schwehn
Merck
Chemical Laboratory Technician
Christian Haider
Metrohm AG
Application Specialist
Pharma and biopharma manufacturing, Solid Formulation Strategies
The Developability Classification System for Poorly Soluble Drug Formulation Strategies
Tune in to our webinar on the developability classification system to learn more about this emerging field of research, which allows more targeted and optimized formulation development of poorly soluble compounds.
Daniel Joseph Price, Ph.D.
Merck
Strategic Marketing Manager
Analytical chemistry, Small molecule HPLC
Taller virtual: Alimentos y bebidas saludables ¿Cómo garantizar la calidad?
Matthias Nold, Ph.D.
Merck
Product Manager, Analytical Standards
Pharma and biopharma manufacturing, Biologics and Biosimilars Characterization
Advantages of Developing Processes and Manufacturing API with Single-Use Technologies
In this webinar, you will learn more about single-use manufacturing and its benefits on risk and speed optimization for scale-up and tech transfer.
Laetitia Botrel
Merck
Head of Business Planning and Operation, BioReliance® portfolio
Jérôme Pionchon
Merck
Global Facility Engineering Expert, BioReliance® portfolio
Analytical chemistry, Analytical chemistry
Proficiency Testing: Critical Tools for Accurate Laboratory Results
Eddy Tan
Merck Pte. Ltd., Singapore
APAC Advanced Analytical Scientist
Research and disease areas, Cancer research
New Developments in Parahydrogen Hyperpolarization Instrumentation
This webinar presents recent advances in hardware development and techniques to support Parahydrogen Hyperpolarization (PHIP) research.
Patrick TomHon
North Carolina State University
Graduate Research Assistant
Pharma and biopharma manufacturing, Viral Vector Upstream Processing
Leveraging Next Generation Raman PAT Platform for Real-Time Bioprocess Monitoring
In this webinar, we discuss how process knowledge is critical to facilitate efficient bioprocess development and manufacturing. Real-time monitoring of upstream process parameters by ProCellics™ Raman Analyzer with Bio4C™ PAT Raman Software speeds up process data acquisition and enables advanced control of quality attributes.
Hemant Garg
Merck
Bio4C™ ProcessPad Product Manager
Kevin Grollier
Merck
PAT Implementation & Support Engineer
Research and disease areas, Metabolism research
Food Lipidomics in Health and Disease
Ameer Taha, Ph.D.
Certo Labs
Sr. R&D Manager
Genomics, qPCR
Normalization of qPCR Data
In this webinar, we will learn the goals of normalization of qPCR data and how to select the best normalization strategy.
Mikael Kubista
TATAA Biocenter
Professor
Genomics, Advanced gene editing
Functional Genomics Screening
In this webinar, you will discover an overview of the broad range of available functional genomic screening technologies, including traditional shRNA, ORF, CRISPR KO, to CRISPRi, CRISPRa and single cell analysis.
Gurpreet Balrey, Ph.D.
Merck KGaA, Darmstadt, Germany
Head of Global Commercial Enablement and EMEA Business Head
Environmental and cannabis testing, Air testing
The Essentials of Air Sampling from Strategy to Solutions
Selecting air monitoring methods and related air sampling media devices, the fundamental differences between active and passive sampling devices, how analytical instrumentation plays a role .
Kristen Schultz
Merck
Global Franchise Product Manager for Air Monitoring & GC Consumables
Pharma and biopharma manufacturing, Sterile Filtration Strategies
Case Studies: How to Incorporate Critical Process Parameter (CPP)
In Part 2 of the webinar, using case studies for multiple drug delivery systems, from generic formulations to complex injectables, our experts will demonstrate how different design options can be utilized.
Ramesh Raju
Merck
Head of Operations BioReliance® Validation Services Lab
Sumit Gupta
Merck
Validation Service Technical Expert, BioReliance® Validation Services
Pharma and biopharma manufacturing, Classical pharma manufacturing
The Viscosity Reduction Platform: Enabling Subcutaneous (subQ) Delivery
In this webinar, we will introduce an excipient platform that makes it possible to combine excipients in ways that can reduce protein viscosity to a greater extent.
Tobias Rosenkranz, Ph.D.
Merck
Senior Manager, Biomolecule Formulation R&D
Pharma and biopharma manufacturing, Sterile Filtration Strategies
Impact of Regulation and Critical Process Parameter (CPP) on Bacterial Retention Testing (BRT) Design
In Part 1 of the webinar, we will discuss the implications of current regulatory trends and how this impacts the expectations for bacterial retention testing studies.
Somasundaram G (Som)
Merck
Senior Consultant
Ramesh Raju
Merck
Head of Operations BioReliance® Validation Services Lab
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Risk-based Approach to Evaluate Nitrosamines and Elemental Impurities from Single-use Components
This webinar looks into how to evaluate nitrosamine and elemental impurity risk related to single-use systems and filters.
Janmeet Anant, Ph.D.
Merck
Senior Regulatory Consultant
Jessica Shea
Merck
Emprove® Program Manager
Protein biology, Western blotting
Winning Westerns Technique Talk: Perfecting Western Blotting
Alli Lynch, Ph.D.
Merck
Application Development Scientist
Analytical chemistry, Titration and Karl Fischer titration
Tips & Tricks to Improve Your Titration Process
Tips & Tricks to Improve Your Titration Process
Bettina Straub-Jubb
Merck
Global Product Manager, Karl Fischer Titration
Thomas Hitz
METTLER TOLEDO
Application Chemist
Pharma and biopharma manufacturing, Cell Line Development
Scientific Comprehension of Cell Line Development Strategy Based on the CHOZN-GS System
In this webinar, we share how cell line development strategies can be flexibly optimized under given conditions through an understanding of the scientific context.
Dr. Young Min Oh
GI Innovation
Managing Director
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Changing Landscape of QC Testing for Emerging Therapies
In this webinar, we discuss how to ensuring the biosafety and quality of emerging therapies through a multi-level approach that examines a number of factors to establish product safety and characterization.
Alison Armstrong, Ph.D.
Merck
Sr. Director, Technical and Scientific Solutions
Pharma and biopharma manufacturing, Biologics and Biosimilars Characterization
PDA Virus Conference Follow Up: What to Expect with ICHQ5A (R2) for mAbs, CGT, and Beyond
New regulatory guidance will impact the next generation of therapies. Our regulatory experts share findings from the 2021 PDA virus conference meeting and guidance to maintain safety and quality across the global landscape.
Manjula Aysola, Ph.D.
Merck
Senior Regulatory Consultant
Kathryn Martin Remington, Ph.D.
Merck
Technical Consultant
Microbiological testing, Pathogen and spoilage testing
Examination of the Regulatory Landscape Related to Food Pathogen Testing
Justyce Jedlicka
Merck
Food & Beverage Regulatory Liaison
Lyssa Sakaley
Merck
Senior Global Product Manager for Molecular Pathogen Testing
Pharma and biopharma manufacturing, Downstream Processing
Keeping the (Adventitious) Virus Out of the (Adeno-Associated) Virus
How can you keep an adventitious virus from contaminating your gene therapy that is delivered by an adeno virus vector? As viral vector bioprocessing advances, regulatory requirements for viral safety will as well. In this webinar, learn how to define your viral clearance strategy for AAV delivered gene therapies.
Ratish Krishnan
Merck
Senior Strategy Consultant
Pharma and biopharma manufacturing, Liquid Formulation Strategies
The Role of Polyvinyl Alcohol (PVA) in Ophthalmic Formulations
Polymers play an important role in ophthalmic formulations, such as lubrication, viscosity modification, stabilization and sustained release. One of the commonly used polymers is polyvinyl alcohol (PVA). This webinar will provide best practices to handle PVA from a process optimization perspective.
Smita Rajput, Ph.D.
Merck
Field Marketing Manager
Protein biology, Protein quantitation
Keeping COVID-19 at Bay: Existing and Induced Antibody Immunity to SARS-CoV-2
Listen to this webinar to gain insights into research on the SARS-CoV-2 antibody responses after infection, vaccination, and in unexposed populations of children and adults. MILLIPLEX® multiplex kits were used as a part of this research.
Todd Bradley, Ph.D.
Children’s Mercy Research Institute
Director of Immunogenomics
Pharma and biopharma manufacturing, Vaccine manufacturing
Platform Technologies to Accelerate Novel Vaccine Development and Manufacturing
In this webinar, we present a comparison of novel technologies, discuss key considerations for manufacturing, and share selected case studies for platforms such as virus-like-particles, viral vectors, plasmid DNA, and mRNA platforms.
David Loong, Ph.D.
Merck
Senior Consultant, Novel Modalities Asia Pacific, Bioprocessing Strategy
Josephine Cheng
Merck
Senior Consultant, Core Modalities Asia Pacific, Bioprocessing Strategy
Clinical testing and diagnostics manufacturing, Clinical and Forensics Testing
Reliable & Consistent Custom Oligos for Commercial Use
Learn how stringent quality control, minimized cross-contamination, and dedicated project management help you accelerate the commercialization of your demanding oligo project.
Tom Russell, Ph.D.
Merck
Product Manager, Custom Products
Pharma and biopharma manufacturing, Cell therapy manufacturing
Achieving High Yields in Scalable Xeno-Free Culture Formats with Mesenchymal Stem Cell Medium
Optimize your mesenchymal stem cell growth. In this webinar, you will learn more about our GMP-compliant, xeno-free media formulation that supports high performance expansions and compatibility with scalable xeno-free manufacturing conditions.
Kathleen Ongena, Ph.D.
Merck
Head of Customer Applications
Mark Ventresco
Merck
Cell Therapy Product Manager
Clinical testing and diagnostics manufacturing, IVD manufacturing
Efficient Scale-up & Manufacture of mAbs for Diagnostics
This webinar describes an approach for efficient scale-up of a bench-scale mAb process.
Paul Beckett
Merck
Senior Manager, Downstream Technologies, BioContinuum™ Platform
Polymer synthesis, Gas chromatography
Living Radical Polymerization
This webinar provides an overview of living radical polymerization (LRP) chemistries and highlights work in the Wooley Lab that utilizes LRP to prepare well-defined block copolymers with controlled macromolecular architectures and reactive functionalities.
Prof. Karen L. Wooley
Texas A&M University
W. T. Doherty-Welch Chair Department of Chemistry
Food and beverage testing and manufacturing, Microbiological analysis
How to Choose Best Adapted Water Quality for Food & Beverage
Estelle Riche, Ph.D.
Lab Water Solutions
Global Application Specialist
Food and beverage testing and manufacturing, Microbiological analysis
New IFU Method No. 12:2019
Andreas Bubert, PhD
Merck
Senior Product Manager, Culture Media Food & Beverage
Pharma and biopharma manufacturing, mRNA
Upcoming USP <665> - Level of Characterization of Single-Use Systems Today and Tomorrow
The new general chapter USP <665> will be a pragmatic move forward to standardization and a baseline of single-use system qualification to identify potential risk related to leachables. In this webinar, we highlight legacy testing requirements which may not be necessary once USP <665> is implemented.
Simone Biel, Ph.D.
Merck
Senior Regulatory Consultant
Pharma and biopharma manufacturing, Liquid Formulation Strategies
Validation of Tangential Flow Filtration in Biotech Processes
This webinar focuses on the validation of the unit operation of TFF and gives an overview of the regulatory landscape, the validation master plan, approaches to membrane re-use, cleaning validation and best practices.
Subhasis Banerjee, Ph.D.
Merck
Principal Bioprocessing Application Expert
Pharma and biopharma manufacturing, mRNA
Make it Right: Best Practices for mRNA Manufacturing
mRNA has taken center stage. Vaccines and therapeutics based on this versatile biomolecule have the potential to transform disease prevention and treatment. This webinar will explore key considerations for efficient mRNA production, starting from facility design and raw materials selection to technologies and strategies used for manufacturing.
Nargisse El Hajjami, Ph.D. Eng.
Merck
Senior Consultant
Shiksha Mantri, Ph.D.
Merck
Global Marketing Manager, RNA Solutions
Pharma and biopharma manufacturing, Biologics and Biosimilars Characterization
Getting it Right. A Candid Conversation about Remote Viral Clearance Studies
Evolving regulatory guidelines and a global pandemic won’t derail your viral clearance study timelines with our Provise™ Clearance services. Learn how we partner with you to perform the viral clearance process steps on your behalf, keeping you informed all the way through successful tech transfer.
Kristen Heslin, BS, MBA, PMP®
Merck
Head of Business Planning and Implementation
Joshua Huffer
Merck
Technical Specialist, Viral Clearance Services
Food and beverage testing and manufacturing, Chemical analysis
How to Choose the Best-Adapted Water Quality for Your Food and Beverage Tests
Join this webinar, “How to Choose the Best-Adapted Water Quality for Food & Beverage Tests” for helpful advice on minimizing water contaminants and tips for choosing an optimal water solution for your analyses.
Elisa Pesco
Merck
ield Sales Specialist, Lab Water Solutions
Emanuele Pirovano
Merck
Associate Director for Regional Sales, Lab Water Solutions
Analytical chemistry, Calibration, qualification, and validation
Proficiency Testing: Ensuring Accurate Laboratory Results
Markus Obkircher, Ph.D.
Merck
Director R&D, Head of Reference Materials and Proficiency Testing
Tomasz Dziedzic
Merck
Scientist, Proficiency Testing R&D
Pharma and biopharma manufacturing, Viral Vector Upstream Processing
Turnkey Solutions for Upstream Cell Culture Processes
What could you accomplish if less time could be spent on process development due to rapid cell culture feed screening process? In this webinar, we explore the benefits of feed mixing and use of chemically defined and protein-quality supplements.
Janice Tan, Ph.D.
Merck
Head of Upstream MSAT, APAC excluding China
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Releasing Your AAV Therapy with Confidence
This webinar will discuss key regulatory considerations across the manufacturing process, from the helper/packaging plasmids through to lot release testing.
Steven McDade
Merck
Associate Director, Sales Development, APAC
Alfonso Lavorgna, Ph.D.
Merck
Operations Manager, Virology Services
Pharma and biopharma manufacturing, mRNA
Optimize Your Process Validation Package
Process validation is a complex step in the transition to commercial scale manufacturing. While quality by design (QBD) is the standard option for a risk-mitigating process validation strategy, there are other options for more flexibility and speed. In this webinar, you will learn how to accelerate your time to market by outsourcing to a CDMO and taking an adaptive, risk-based validation approach.
Christian Cattaruzza
Merck
Director of International Marketing, BioReliance® End-to-End Solutions
Corinne Lavie-Cambot
Merck
Head of Innovation and Industrialization Department, BioReliance® End-to-End Solutions
David Delvaille
Merck
Head of Process Validation, BioReliance® End-to-End Solutions
Genomics, Research and disease areas
Detection of SARS-CoV-2 Variants Using Multiplex RT-qPCR
Vikas Palhan, Ph.D.
Merck
Molecular Diagnostics Solutions
Pharma and biopharma manufacturing, Solid Formulation Strategies
2021 Virtual PEG Symposium
This technical symposium is a unique opportunity to discover enabling technologies and today's trends in the broad field of pharmaceutical PEG applications, development, and processing.
Lisa McDermott
Merck
Director Process and Analytical Development
Lars Albermann, Ph.D.
Merck
Head of Pharma Registration and Regulatory Projects
Tobias Haag, Ph.D.
Merck
Head Process and Analytical Development, Schaffhausen
Marco Passafaro, Ph.D.
Merck
Senior Scientist, R&D Drug Delivery Compounds
Research and disease areas, Cancer research
Induction of Receptor Tyrosine Kinase Signaling by Sera Isolated from Patients with Lung Adenocarcinoma
Jeffrey A. Borgia
Rush University Medical Center Chicago, IL USA
Associate Professor
Lie Wen-Rong
Merck
Principal Scientist
Materials science and engineering, 3D bioprinting
Properties and Applications of Advanced 2D Materials: From Graphene to MXenes
2D materials with a thickness of one nanometer or less can be used as single sheets or as building blocks for heterostructures and metamaterials, due to their unique properties and ability to (self)assemble into a variety of structures.
Dr. Yury Gogotsi
Drexel University
Professor of Materials Science and Engineering
Clinical testing and diagnostics manufacturing, Microbiological testing
Bioburden and Sterility Testing of IVD Products
Anne Connors
Merck
Senior Field Marketing Manager
Microbiological testing, Pyrogen testing
Risk Considerations for the Presence of Pyrogens and the Need for the MAT Test in Pharmaceutical Processing
Tim Sandle
University of College London & University of Manchester
Head of Microbiology at BPL and visiting tutor
Microbiological testing, Bioburden testing
Robotics & Automation: Anticipating and Implementing Laboratory Transformation, with its Opportunities and Challenges
Marilyn Romieux
Merck
Director of Strategic Marketing Pharma
Microbiological testing, Sterility testing
What to look for in a CDMO Selection, and How to Stand Out in the Race
Bryan Lowery
Quality System Consulting, Inc.
Pharmaceutical Consultant
Microbiological testing, Sterility testing
Connecting Further with Our Customers Via Learn@M + Val@M “Digital Services and Technical Training for a More Competent & Confident Workforce”
Carine Krebs
Merck
Global Product Manager Services
Microbiological testing, Bioburden testing
Sustainability “What Would a Sustainable QC Lab Look Like? Let’s Start Our Common Journey for a Better World”
Cecile Delbos
Merck
Innovation & Execution Manager
Joseph Burton
Merck
Instruments & Digital Automation Engineer
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Smart Bioprocess Data Management for Statistical Process Control and Advanced Analytics
In this presentation, we highlight the current challenges of bioprocessing data utilization and introduce the solution. WE demonstrate the benefits of the Bio4C™ ProcessPad and real-time monitoring of the ProCellics™ Raman analyzer.
Takao Ito, Ph.D.
Merck
Principal Consultant, Asia Pacific Global BioPharm CoE
Hemant Garg
Merck
Bio4C™ ProcessPad Product Manager
Analytical chemistry, Photometry and reflectometry
Quickly Analyze Chemical Disinfectant Parameters of Your Production Line after Disinfection
Saskia Neubacher, Ph.D.
Merck
Global Product Manager for Rapid Chemical Testing
Chemistry and synthesis, Chemistry and synthesis
Common Classification of Chemicals and Customized Services for Mass Production
In this webinar, you will learn about the selection of chemical drug grades as well as about mass production service and customized product customization.
Wendy Liu
Merck
Product Manager
Pharma and biopharma manufacturing, Gene therapy manufacturing
Unveiling the Potential of your AAV Gene Therapy: Orthogonal Methods to Understand and Define CQAs
Ensure your Adeno-Associated Virus (AAV) is safe throughout its entire drug development journey. In this webinar, you will learn methods that will help you speed to clinic, potentially treating diseases sooner and with greater effectiveness.
Martin De Cecco, Ph.D.
Merck
Technology Lead, Product Characterization
Piotr Kaczmarek, Ph.D.
Merck
Principal Scientist, Analytical, Testing R&D Services
Pharma and biopharma manufacturing, Sterile Filtration Strategies
EU GMP Annex 1 Draft – Implications on Filtration and Single Use Technology
What are the major drivers for the new Annex 1? In this webinar, you will learn more about the implications for filters and single use.
Somasundaram G (Som)
Merck
Senior Consultant
Simone Biel, Ph.D.
Merck
Senior Regulatory Consultant
Chemistry and synthesis, Reaction design and optimization
Advances to SYNTHIA™ Retrosynthesis Software and How They Have Accelerated Chemical Development at GlaxoSmithKline (GSK)
Ewa Gajewska, Ph.D.
Merck
Manager, Chemistry Development
John Jin Lim
GlaxoSmithKline plc (GSK)
Senior Scientist
Microbiological testing, Microbial culture media preparation
GMP Annex 1: Changes in Microbial Monitoring
Listen to our podcast, GMP Annex 1: Changes in Microbial Monitoring.
Dr. Anne-Grit Klees
Merck
Global Product Manager Environmental Monitoring
Adèle Gisselmann
Merck
Global Product Manager Environmental Monitoring
Analytical chemistry, Titration and Karl Fischer titration
USP <921>: Methods for Moisture Determination and Karl Fischer Titration
This poster will discuss the application of three methods (Method I-Titrimetric, Method II-Azeotropic, or Method III-Gravimetric) to moisture determinations focusing on Karl Fischer techniques.
Bruce Herzig
Senior Application Specialist
Analytical chemistry, Analytical chemistry
Sample Preparation for Chromatography
Eugenia Peña
Merck
Researcher
Food and beverage testing and manufacturing, Microbiological analysis
How to Choose the Best-Adapted Water Quality for Your Food and Beverage Tests
Miguel Angel Garcia Martin
Merck
Field Sales Specialist, Lab Water Solutions
Jorge Nicolás
Merck
Associate Director for Regional Sales, Lab Water Solutions
Research and disease areas, Pharmacology and drug discovery research
Sanger Arrayed CRISPR Screening in partnership with Evotec
Shawn Shafer, Ph.D.
Advanced Genomics Market Segment Manager
Merck
Hauke Cornils, PhD
Merck
Research Scientist In Vitro Pharmacology
Research and disease areas, Pharmacology and drug discovery research
Filtration in Dissolution Testing: Improving Throughput and Reducing Variability
Vivek Joshi, Ph.D.
Merck
Applications and Market Adoption Manager
Protein biology, Protein expression
Protein Sample Prep Tips & Tricks: Improving protein yield and purity from Recombinant Bacterial Expression
Natasha L. Pirman, Ph.D
Molecular Workflow Tools
Lead Application Scientist
Analytical chemistry, Low pressure liquid chromatography
HPLC Column Fundamentals: Terms & Relationships
Richard Henry
ACS Subdivision on Separations
Chairman
Protein biology, Protein expression
High Protein Yields in Shaken Cultures by EnPresso Growth System
Dr. Kaisa Ukkonen
BioSilta
Head of Protein Expression Technologies
Dr. Antti Vasala
BioSilta
R & D Director
Microbiological testing, Pathogen and spoilage testing
Campylobacter Talk
Andreas Bubert, PhD
Merck
Senior Product Manager, Culture Media Food & Beverage
Analytical chemistry, Solid phase extraction
New Preparation Approach for Improved Pesticide Analysis of Challenging Samples
This webinar will introduce new sample preparation approaches leading to improved clean-up and recovery of pesticides in these challenging matrices.
Dr. Frank Michel
Merck KGaA, Darmstadt, Germany
Analytical & Chromatography Scientific Advisor
Cell culture and analysis, 3D cell culture
3D Cell Culture Innovations
In this webinar, we discuss features of the Perfecta3D Hanging Drop Plates and Cell-in-a-Box live cell encapsulation system for 3D cell culture.
Dr. Nicky Slawn
3D Biomatrix
Applications Director 3D Biomatrix
Dr. John Dangerfield
Austrianova
Chief Operating Officer Austrianova
Pharma and biopharma manufacturing, Liquid Formulation Strategies
Excipients Selection for High Risk Formulation
Smita Rajput, Ph.D.
Merck
Field Marketing Manager
Pharma and biopharma manufacturing, Solid Formulation Strategies
When Coating runs smoothly: Enhance Your Coating Process with a new Particle designed PVA
This webinar covers coating formulation development as well as novel technologies for characterization of coated tablets that can easily be implemented during production.
Thomas Kipping, Ph.D.
Merck
Head of Drug Carriers
Protein biology, Flow cytometry
Duolink® PLA Technology: How to detect and quantify protein webinar
Holly Johnston, Ph.D.
Merck
Product Manager - Duolink®
Cláudia Emanuele
Merck
Field Marketing Specialist
Pharma and biopharma manufacturing, Cell Line Development
Setting up for Successful Lot Release Testing
In this presentation, we will cover the CMC testing requirements with CHO production platform for global commercialization, lot release testing of product intermediates and final product.
Edmund Ang, Ph.D.
Merck
Senior Technical Specialist
Protein biology, Enzyme activity assays
Enzyme Explorer Library: Navigation and Application
Robert Gates
Merck
Market Segment Manager, Protein Technologies and Assays
Cell culture and analysis, Primary cell culture
Successful Primary Cell Cultures: Improve the Reproducibility of your Research with Standardised Primary Cell Culture Techniques
Successful Primary Cell Cultures: Improve the Reproducibility of your Research with Standardised Primary Cell Culture Techniques
Lisa Schmidtke
PromoCell
Product Manager Cells & Media
Pharma and biopharma manufacturing, Downstream Processing
Single-Use Tangential Flow Filtration for Closed Processing
Closed processing involves use of physical barriers to separate processing fluid from the external environment. This approach reduces capital expenditures and clean room classification while accelerating time to market. This webinar will present a TFF process run in a closed mode.
Dana Kinzlmaier
Merck
Applications Engineer
Sarah Le Merdy
Merck
Strategy Deployment, Single-Use and Systems
Analytical chemistry, Food and beverage testing and manufacturing
Sample Preparation for Fatty and Complex Food Matrices
Sample Preparation for Fatty and Complex Food Matrices
Klaus Buckendahl
Merck
Analytical Sciences Liaison
Pharma and biopharma manufacturing, Cell therapy manufacturing
Breaking the Status Quo: Using Mass Spectrometry to Identify and Quantify Host Cell Proteins
In this webinar, we will discuss how mass spectrometry (MS)-based approaches coupled with ELISA methods help detect qualitative and quantitative differences in HCP populations.
Protein biology, Protein mass spectrometry
Quantitative Lipidomics
Gavin E. Reid, PhD
University of Melbourne
Professor of Bioanalytical Chemistry
Pharma and biopharma manufacturing, Biologics and Biosimilars Characterization
CDMO Case Study: Be Ready for Commercial-Scale Single-Use Manufacturing!
Taking biologics manufacturing to commercial scale is a complex, yet exciting, journey as you are nearing market and helping patients in need. How do you minimize risk and maximize efficiency to be ready for success? Learn how R-Pharm leverages our CDMO partnership to help accelerate market readiness.
Sébastien Ribault, Ph.D.
Merck
Vice President and Head of BioReliance® End-to-End Solutions
Kira Ivanova
R-Pharm
VP, Own Brands, International Marketing
Microbiological testing, Media fills
Key Challenges when Selecting Media for Media Fill Tests
Adèle Gisselmann
Merck
Global Product Manager Environmental Monitoring
Pharma and biopharma manufacturing, Viral Vector Upstream Processing
Right First Time: Manufacturing Platform Development for Viral Vectors
Platform production processes simplify process development and make it easier to scale-up effectively. Similarly, a platform analytical testing strategy reduces the time for assay development. In this webinar, we describe key considerations when building such an integrated platform for viral vectors, and propose near-term and future-state solutions.
David Loong, Ph.D.
Merck
Senior Consultant, Novel Modalities Asia Pacific, Bioprocessing Strategy
Chemistry and synthesis, Lead discovery
Tools for Early Discovery and MedChem
Ben Glasspoole
Merck
Head of Emerging Chemical Synthesis
Pharma and biopharma manufacturing, Solid Formulation Strategies
Don’t Feed the Trolls – Crazy Powders and Electrostatic Charge in Continuous Manufacturing
Powder feeding is crucial for a robust continuous manufacturing (CM) operation and product quality.
Theresa Hörmann-Kincses
Merck
Senior Scientist, Process and Manufacturing Science Research Center for Pharmaceutical Engineering (RCPE)
Michela Beretta
Merck
Scientist, Process and Manufacturing Science Research Center for Pharmaceutical Engineering (RCPE)
Materials science and engineering, Photovoltaics and solar cells
Perovskite Solar Cells: A New Paradigm in the Energy Sector
Mohammad Khaja Nazeeruddin
École Polytechnique Fédérale de Lausanne, Switzerland
Professor
Clinical testing and diagnostics manufacturing, IVD manufacturing
Optimized Lateral Flow Test Strips: Design Considerations for Optimal Performance
Michael Mansfield, Ph.D.
Merck
Applications Development Scientist
Research and disease areas, Pharmacology and drug discovery research
How FAIR Lab Data Can Expedite Your Drug Discovery AI Programs?
This webinar will explore the hidden costs that data silos and proprietary file formats have—from manual data-cleansing to compliance to enterprise-wide digital transformation.
Hayden Boehm
Merck
Head of Commercial Marketing
Pharma and biopharma manufacturing, Compendial Testing and Regulatory Guidance
Turning up the Compen-DIAL: Rapid Test Methods for Cell & Gene Therapies
In this webinar, find out how we turn up the dial on quality control testing for cell and gene therapies through rapid methods for sterility, mycoplasma, and replication competent virus. We will review the current regulatory expectations as well as the benefits and limitations that come with each method.
Kyle Reder
Merck
Segment Strategy Manager for Cell & Gene Therapy
Sarah Sheridan, Ph.D.
Merck
Technical Consultant
Pharma and biopharma manufacturing, Solid Formulation Strategies
Amorphous Formulations for Bioavailability Enhancement: Risks and Opportunities
In this webinar, you will learn about the advantages and risks of amorphous formulations and strategies for ensuring stabilization of challenging compounds.
Daniel Joseph Price, Ph.D.
Merck
Strategic Marketing Manager
Microbiological testing, Viable air monitoring
EN 17141 & Active Air Sampling
Dr. Anne-Grit Klees
Merck
Global Product Manager Environmental Monitoring
Protein biology, Protein quantitation
xPLOREing possibilities on the SMCxPRO® platform: Development of an ultra-sensitive PK assay using custom assay services
Hear about the development of an ultra-sensitive pharmacokinetic (PK) assay using SMC™ technology.
Allison Chunyk
Aptevo Therapeutics
Principal Scientist
Protein biology, Protein quantitation
Single Molecule Counting (SMC®) Technology Enables Acceleration of Drug Development Programs
Single Molecule Counting (SMC®) Technology Enables Acceleration of Drug Development Programs
Anitaben Tailor, Ph.D.
Merck
Biology Technical Marketing
Research and disease areas, Research and disease areas
Clinical Translation of Combined Hyperpolarized [1-13C]pyruvate and [13C, 15N2]urea MRI for Simultaneous Metabolic and Perfusion Imaging
This webinar discusses advances in the use of stable isotope labeled tracers during hyperpolarization and MRI to follow perfusion and metabolism in cancer cells.
Hecong Qin
University of California, San Francisco
Postdoctoral Researcher, UCSF Bioengineering
Pharma and biopharma manufacturing, Antibody drug conjugate manufacturing
Integrated Approach to Support ADC Programs From Concept to Clinical Material
As the ADC industry moves forward, we need to look at the development and manufacturing process from an end-to-end perspective. Maintaining a holistic approach to evaluate the entire process can save time, money, and headaches as you near the finish line. We will demonstrate this through a seamless characterization from the mAb raw material to the final ADC construct.
Daniel Galbraith, Ph.D.
Merck
Head of Product Characterization Strategy
Omar Lamm
Merck
Global Head of Analytical Services and Development
Jeffery Carroll
Merck
Senior Scientist, Team Lead ADC Express, Process and Analytical Development
Pharma and biopharma manufacturing, Downstream Processing
High Concentration Ultrafiltration: Formulation Challenges & Mitigation Strategies
Are you working on a high concentration mAb subcutaneous formulation? Join us to find out how to overcome buffer offsets in the formulation UF-DF step.
Subhasis Banerjee, Ph.D.
Merck
Principal Bioprocessing Application Expert
Pharma and biopharma manufacturing, Sterile Filtration Strategies
Does PUPSIT Reduce Risk for Sterile Filtration?
Recent PDA/BioPhorum publications outline risks for PUPSIT in sterilizing filtration. This webinar will summarize the key points and best practices for implementing PUPSIT.
Janmeet Anant, Ph.D.
Merck
Senior Regulatory Consultant
Andrew Koch
Merck
Technology Manager, Sterile Filtration
Pharma and biopharma manufacturing, Liquid Formulation Strategies
Addressing Raw Material Handling Challenges by Dry Granulation
Caking and clumping of pharmaceutical raw materials have a negative impact on manufacturing efficiency. In this webinar, learn which benefits dry granulation provides and how granulated raw materials facilitate processability, speed up manufacturing processes, and increase operator safety.
Thomas Briel, Ph.D.
Merck
Strategic Marketing Manager, Excipients Liquid Application
Pharma and biopharma manufacturing, Bioreactor Production
Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Production in Suspension
In this webinar, we will highlight critical considerations when moving from bench-scale to clinical scale process design with manufacturability in mind to ensure commercial readiness.
Eva Fong
Merck
Senior Scientist , Virus & Gene Therapy Bioprocessing
Protein biology, Protein quantitation
Development of Ultrasensitive Immunoassays for SARS-CoV-2 Antibody Detection
Rosemary Sweetwood
Manager, CAST Sample Testing, Scientist II CAST Custom Assay Development
Merck
Microbiological testing, Food and beverage testing and manufacturing
What You Need to Know About the New ISO 16140-3 Microbiological Method Verification
This on-demand webinar introduces the new EN ISO 16140-3 on the verification of methods in food microbiology.
Barbara Gerten
Merck
Senior Scientist Traditional Microbiology
David Tomás Fornés
Merck
Application Specialist
Andreas Bubert, PhD
Merck
Senior Product Manager, Culture Media Food & Beverage
Protein biology, Protein quantitation
IgG Antibodies Against SARS-CoV-2 Correlate to Days from Symptom Onset in COVID-19 Positive Patients
IgG Antibodies Against SARS-CoV-2 Correlate to Days from Symptom Onset in COVID-19 Positive Patients
Mary Young
University of Virginia, School of Medicine
Research Technician
Pharma and biopharma manufacturing, Cell Line Development
Does Your Cell Line Have a Secret? Avoid Surprises with Characterization
Kathryn Martin Remington, Ph.D.
Merck
Technical Consultant
Alberto Santana, MBA
Merck
Product Manager, Biologics Biosafety Testing
Pharma and biopharma manufacturing, Pharma and biopharma manufacturing
Smart Data Management and Advanced Analytics with Bio4C™ ProcessPad
In this webinar, you will learn about the Bio4C™ ProcessPad, a data visualization, advanced analytics, and process monitoring platform that enables bioprocess lifecycle management, reporting, investigations, and continued process verification (CPV).
Hemant Garg
Merck
Bio4C™ ProcessPad Product Manager
Protein biology, Protein quantitation
The Dynamics of SARS-CoV-2 Specific Antibody Responses in COVID-19 Patients
Gain insights into research conducted on SARS-CoV-2 samples using MILLIPLEX® multiplex kits.
Christine S. Falk, Ph.D.
Hannover Medical School
Full Professor for Transplant Immunology; Director, Institute of Transplant Immunology
Christine Kornmeier
Merck
Global Product Manager, Immunoassay Platform Solutions
Materials science and engineering, Drug delivery
Nanomedicine – Translating Drug Delivery Formulations to Advance Drug Discovery
Nicolynn Davis, Ph.D.
Merck
Head of Materials Science Product Innovation
Rajiv Kumar, Ph.D.
Merck
Technical Lead and Senior Formulation Scientist
Ben Knappett, Ph.D.
Dolomite Microfluidics
Head of Scientific R&D
Environmental and cannabis testing, Drinking water testing
Good Water Practices for Reliable LC–MS and ICP-MS Analyses
In this webinar, Estelle Riché, Global Application Specialist at Milli-Q® Lab Water Solutions Merck, will discuss how water is purified for the most sensitive analytical techniques, will provide guidance on how to select the optimal water purification solution, and will give tips on preventing water contamination for optimal experimental results.
Estelle Riche, Ph.D.
Lab Water Solutions
Global Application Specialist
Materials science and engineering, Drug delivery
Nanotechnology: Enabling Drug Delivery Breakthroughs
In this talk, you will find an interesting discussion about the use of nanoparticles applied in drug delivery studies.
Dr. Henrique Toma
Merck
Professor at the Institute of Chemistry - University of São Paulo (Brazil)
Dr. Marcelo J. Kogan
Merck
Professor in the Department of Pharmacology and Toxicology at the Faculty of Pharmacy at the University of Chile
Dr. Galo Juan de Avila Arturo
Merck
Associate Professor at FCEN, UBA and Dean of the Institute of Nanosystems, University of San Martín, Argentina
Pharma and biopharma manufacturing, Antibody drug conjugate manufacturing
Tackling the Challenges of Single-use Manufacturing for ADCs
Join us to learn more about single-use (SU) processing for ADC GMP manufacturing. Starting in 2017, we established a full SU template for ADC development and manufacturing and have continued to enhance this platform. The presenters will discuss our learnings and provide case studies that highlight the advantages of moving to SU-templated processes.
Lisa McDermott
Merck
Director Process and Analytical Development
Gary Conway
Merck
Principal Production Scientist
Pharma and biopharma manufacturing, Solid Formulation Strategies
Nanoparticulate Impurities in Excipients – A Threat to Protein Stability
Pharmaceutical-grade sucrose – an important stabilizer for biopharmaceuticals – contains nanoparticulate impurities (NPIs) that are a potential threat to protein stability. The scientists behind the discovery explain their impact on drug development and introduce a new sucrose with low NPI content.
Andrea Hawe, Ph.D.
Coriolis Pharma
Chief Scientific Officer
Daniel Weinbuch
Coriolis Pharma
Analytical Service Specialist
Protein biology, Protein quantitation
High-Sensitivity Immunoassays for Biomarkers of Huntington’s Disease
Learn about the challenges of moving biomarker assays from a research-grade non-GLP laboratory to a clinical-grade GLP laboratory.
Chantal Bazenet
Evotec SE, Germany
Cell Biologist
Elena Vicentini
Aptuit Srl, an Evotec Company, Italy
Biotechnologist
Pharma and biopharma manufacturing, Solid Formulation Strategies
Continuous Manufacturing in Solid Dose: How to Leverage Opportunities of this New Technology
This webinar on continuous manufacturing in solid dose will discuss challenges of this new technology, point out critical parameters and show how to tackle these by choice of excipients.
Leo Ohrem
Merck
Strategic Marketing Manager
Microbiological testing, Viable air monitoring
MAS-100 NT | Validation of the HEPA Filter
Anne-Grit Klees
Merck
Global Product Manager Environmental Monitoring
Microbiological testing, Media fills
Media Selection Made Easy
In this webinar, our media fill experts give an overview of what to consider when selecting media for aseptic process simulations.
Adèle Gisselmann
Merck
Global Product Manager Environmental Monitoring
Tim Cser
Merck
Sr. Technology Specialist
Chemistry and synthesis, Chemistry and synthesis
SYNTHIA™ Retrosynthesis Software for Practicing Chemists
Emma Gardener
Merck
Ph.D. Technical Application Scientist
Protein biology, Protein quantitation
Immune Responses in Severe COVID-19 Patients
Listen to this research talk on SARS-CoV-2 to gain an understanding of the immune response in severe COVID-19, and how this information may help researchers better understand SARS-CoV-2 mechanisms.
Prof. Dexi Chen
Beijing Institute of Hepatology
Professor and Director
Protein biology, Protein quantitation
MILLIPLEX® Multiplex Immunoassays for Use in COVID-19 and Cytokine Storm Research
Hear about how MILLIPLEX® multiplex immunoassays can help researchers understand the immune response to SARS-CoV-2, and how to integrate these assays into a lab’s workflow.
Brooke Gilliam
Merck
Global Product Manager, Immunoassay Platform Solutions
Clinical testing and diagnostics manufacturing, IVD manufacturing
The Secret to ELISA-based Diagnostic Test Success: Know Your Water
Estelle Riche, Ph.D.
Lab Water Solutions
Global Application Specialist
Patricia Schnulle
Merck
Strategic Business Manager, Milli-Q® Lab Water Solutions
Pharma and biopharma manufacturing, Solid Formulation Strategies
PVA for Sustained Release: Theory and Practice
This webinar will introduce PVA as an optimized excipient for sustained release formulations. Combining direct-compression compatibility with a robust and reliable matrix formation, PVA has the potential to enhance sustained release formulations.
Gudrun Birk, Ph.D.
Merck
Head of Controlled Release
Research and disease areas, Neuroscience research
Quantification of Mutant and Total Huntington Protein Levels
Sarah Hamren
Merck
Former Head of Custom Assays & Sample Testing Group
Microbiological testing, Pathogen and spoilage testing
HybriScan Rapid Test System - In Situ Hybridization
Jvo Siegrist
Merck
Senior Global Product Manager Media & Specialty
Pharma and biopharma manufacturing, Final Sterile Filtration
Improved Design Reduces Contamination Risks in Final Filtration & Filling Processes
This webinar will focus on final filtration and filling in single-use assemblies. We will focus on new product and system designs that help customers meet regulatory expectations and reduce contamination risk while maximizing product recovery.
Chuck Raye
Merck
Product Manager, Final Fill Single Use Systems
Food and beverage testing and manufacturing, Microbiological analysis
Pooling Samples in Microbiological Analysis of Food
David Tomás Fornés
Merck
Application Specialist
Pharma and biopharma manufacturing, Antibody drug conjugate manufacturing
Commercializing Antibody Drug Conjugates: A CMO’s Journey
This webinar will take you through the story of a CMO preparing for the manufacture of a Commercial Antibody Drug Conjugate (ADC).
Elizabeth McKee
Merck
Commercial Project Manager
Jake Spies
Merck
Senior Scientist Group Lead Process & Analytical Development
Kerry Keith
Merck
Head of Site Quality
Food and beverage testing and manufacturing, Microbiological analysis
How to Choose the Best-Adapted Water Quality for Your Food & Beverage Tests
In this webinar, you will gain a deeper understanding about the potential impact of water purity on your laboratory results. You will receive practical advice on how to select the most appropriate water quality to prepare microbiology media, especially as it refers to supporting compliance with the ISO® 11133 standard. The impact of water quality on sensitive analytical techniques, such as LC-MS, ICP-MS and molecular biology, will also be discussed. Strategies for overcoming the challenges posed by water contaminants will be provided.
Estelle Riche, Ph.D.
Lab Water Solutions
Global Application Specialist
Clinical testing and diagnostics manufacturing, IVD manufacturing
Applying AnteoBind™ Activated Estapor® Europium Microspheres for Development of Fluorescent Lateral Flow Immunoassays
In this webinar, we share best practices to troubleshoot antibody conjugation to AnteoBind™ activated Estapor® europium microspheres in assay development and initial scale-up procedures.
Clinical testing and diagnostics manufacturing, IVD manufacturing
The Secret to ELISA-Based Diagnostic Test Success: Know Your Antibody
Michael Moehlenbrock, Ph.D.
Merck
Business Development Manager - Diagnostic Immunoassays
Christina De Wit
Cell Marque Corporation
R&D Manager, Tissue Diagnostics
Matthew Coussens
Merck
Ph.D., Product Training Manager
Analytical chemistry, Food and beverage testing and manufacturing
Measuring Ethanol in Kombucha Tea by HS-SPME
Measuring Ethanol in Kombucha Tea by HS-SPME
Katherine Stenerson
Merck
Analytical Sciences Liaison, North America Applied Markets
Analytical chemistry, Solid phase extraction
Solid Phase Extraction: Fundamentals and Recent Developments
This webinar provides an overview of the available SPE phases, as well as tips on how to choose the right phase for selected applications.
Olga Shimelis
Supelco Inc
Principal R&D Scientist
Protein biology, Protein quantitation
Optimizing Nutrition Supplementation to Alter Muscle Recovery Time Course
We will explore nutritional countermeasures to muscle damage that have strong scientific evidence supporting their efficacy.
Brian K. McFarlin
University of North Texas
PhD, FACSM, Associate Professor in the Departments of Kinesiology
Protein biology, Protein quantitation
Use of a 48-Plex Quantitative Immune Panel to Profile Three Different Diseases
Anna Lokshin
University of Pittsburgh Cancer Institute
Professor, Medicine, Pathology, Ob/Gyn; Director Luminex Core
Protein biology, Protein and nucleic acid interactions
Detection of Signaling Effector-Complexes Downstream of BMP4 Using In Situ PLA, A Proximity Ligation Assay
Efstathia Thymiakou
Medical Research Council - Clinical Sciences Centre
Faculty of Medicine
Vasso Episkopou, Ph.D.
Faculty of Medicine, Department of Brain Sciences
Professor in Developmental Biology
Food and beverage testing and manufacturing, Microbiological analysis
Quality Assurance in Microbiological Laboratories
David Tomás Fornés
Merck
Application Specialist
Pharma and biopharma manufacturing, Cell Line Development
Take the Right Path Upstream: An Integrated Solution for Cell Line and Process Development
Learn how our high-performing integrated upstream solutions can help you go from gene to bioreactor harvest with reduced resources. This webinar will show how we incorporated novel technologies and products into our upstream platform to address the key bottlenecks in upstream processing.
Brandon Medeiros
Merck
Upstream Process Engineer
Patricia Kumpey
Merck
Associate Scientist
Protein biology, Protein quantitation
High-Throughput Biomarker Profiling for Immuno-Oncology Research Using MILLIPLEX® Assays at BMS
Hear about the benefits of using multiplexed biomarker profiling from early to late stages of an immuno-oncology discovery project.
Jennifer Koenitzer, Ph.D.
Bristol Myers Squibb
Principal Scientist, Clinical Mechanisms
Yan Nikhamin, MS, MBA
Merck
Immunoassay Platform Specialist
Protein biology, Protein quantitation
Single Molecule Counting (SMC®) Technology - How Low Can You Go?
Learn more about the sensitivity of Single Molecule Counting (SMC®) technology.
Shane Curran
Merck
Immunoassay Platform Solutions Specialist
Sarah Hamren
Merck
Former Head of Custom Assays & Sample Testing Group
Food and beverage testing and manufacturing, Microbiological analysis
Update of the IFU Method No. 12 for Alicyclobacillus spp
Luis Costa
Merck
Field Marketing Manager LATAM
Protein biology, Protein quantitation
Industry Guidelines for Multiplex Assay Selection
Get guidance on selecting the right multiplex biomarker immunoassay for your research.
Lawrence Rentoul
Merck
Portfolio Lead, ELISAs & Specialty Assays
Pharma and biopharma manufacturing, Viral Vector Upstream Processing
Riding the Gene Therapy Roller Coaster: Journey through Tech Transfer to Commercialization
Learn how our integrated approach can help you navigate the twists and turns of gene therapy process development and tech transfer all the way through to commercial readiness. This talk will shed light on process development for viral vector manufacturing, analytics and commercial readiness.
Ratish Krishnan
Merck
Senior Strategy Consultant
Pharma and biopharma manufacturing, Solid Formulation Strategies
The Importance of Amorphous Stability: Mesoporous Silica for Poor Glass Formers
This webinar will discuss the theory of amorphous stabilization followed by a discussion on mesoporous silica as an emerging approach for optimal stabilization of poor glass formers versus traditional polymeric ASDs.
Daniel Joseph Price, Ph.D.
Merck
Strategic Marketing Manager
Environmental and cannabis testing, Drinking water testing
Testing for E. coli and Coliforms in Drinking Water According to ISO 9308-1
Testing for E. coli and Coliforms in Drinking Water According to ISO 9308-1
Andreas Bubert, PhD
Merck
Senior Product Manager, Culture Media Food & Beverage
Pharma and biopharma manufacturing, Cell Line Development
Novel Perfusion Filter and Controller for N-1 Application
In this webinar, we present a case study utilizing our novel perfusion filter and controller along with newly developed expansion medium, demonstrating an ideal solution to intensify upstream processing.
Alison Dupont
Merck
Senior Applications Engineer, Single-Use and Integrated Systems
Allyson Fournier
Merck
Application Engineer, Single-Use and Integrated Systems R&D
Microbiological testing, Microbial culture media preparation
ISO 11133 Culture Media Quality Assurance
Barbara Gerten
Merck
Senior Scientist Traditional Microbiology
Genomics, Advanced gene editing
CRISPR Tools and Technologies for Accelerating Research
Casey Jowdy, Ph.D.
Merck
CRISPR Product Specialist, Genome Editing Tools
Pharma and biopharma manufacturing, Cell Line Development
Media and Process Development for Seed Train Intensification
In this webinar, you will learn about the critical role that media compositions play IN biopharmaceutical production. Applying high cell density cryopreservation and the right combination of media, specifically designed for their purposes, can significantly decrease timelines and increase productivity in the final production stage.
Mona Bausch
Merck
Scientist, Cell Culture Media and Perfusion System R&D
Clinical testing and diagnostics manufacturing, IVD manufacturing
Microfluidic Devices and Systems: A Two-Part Webinar Series
This two-part webinar provides a broad overview of all aspects of microfluidic devices and systems as an enabling technology for new diagnostics product development.
Dr. Holger Becker
microfluidic ChipShop GmbH
Co-founder and CSO
Cell culture and analysis, Mammalian cell culture
Getting Your Buffers Right: How to Control the pH of Cell Culture Medium
In this webinar, we will cover controlling the acid-base balance of culture media and buffer combinations that can result in poor pH control, non-intuitive outcomes, and erroneous inferences.
Pawel Swietach, PhD
Department of Physiology, Anatomy & Genetics, Oxford University
Associate Professor in Cardiovascular Physiology
Protein biology, Immunohistochemistry
Clone Wars - An In Depth Look at Mouse vs Rabbit Antibodies
Faris Omary
Merck
International Distributor Account Manager
Leah Hartman
Merck
Account Manager - Tissue Diagnostics
Microbiological testing, Viable air monitoring
Avoiding Cross Contamination during Viable Active Air Sampling in Clean Rooms
Anne Grit Klees
Merck
Global Product Manager Environmental Monitoring
Roland Durner
MBV AG
Head of Sales and Marketing
Tony Ancrum
Merck
Global Product Manager Environmental Monitoring
Protein biology, Protein lysis and extraction
RNA Extraction and Purification
Natasha L. Pirman, Ph.D
Molecular Workflow Tools
Lead Application Scientist
Protein biology, Protein quantitation
High Sensitivity Measurement of Immunogenicity is Important for Patient Safety
High Sensitivity Measurement of Immunogenicity is Important for Patient Safety
Daniel Garcia-West
Merck
Field Marketing Manager
Food and beverage testing and manufacturing, Chemical analysis
Lab Efficiency and the Impact on Food Testing Labs
Lab Efficiency and the Impact on Food Testing Labs
Materials science and engineering, Organic electronics
Carbon Nanomaterials – Discover Some of the Most Exciting Advancements in Nanomaterials
Learn more about recent advances in carbon nanomaterials.
Na Li
Merck
Global Product Manager for Electronic Materials
Microbiological testing, Viable air monitoring
Environmental Monitoring in Aseptic Isolator Manufacturing
Anne Grit Klees
Merck
Global Product Manager Environmental Monitoring
Tony Ancrum
Merck
Global Product Manager Environmental Monitoring
Research and disease areas, Cancer research
Famous Cancers
Using the fascinating world of celebrities to introduce the immunohistochemical grid approach to cancer disease states.
Nicole Lewis
Merck
Account Manager Tissue Diagnostics
Protein biology, Immunohistochemistry
Soft Tissue Cancer and Immunohistochemistry
This discussion covers the key facts and statistics about soft tissue tumors and what role IHC plays in these difficult diagnoses.
Jeff Gordon
Merck
OEM Sales Manager
Microbiological testing, Pathogen and spoilage testing
Food Microbiology Regulatory Update: New & Revised ISO 11133 and ISO 17410 Standards
This webinar explains the latest changes in ISO 11133 (including its amendments) and ISO 17410, and provides an outlook on the future of these and other ISO standards.
Barbara Gerten
Merck
Senior Scientist Traditional Microbiology
Andreas Bubert, PhD
Merck
Senior Product Manager, Culture Media Food & Beverage
Protein biology, Immunohistochemistry
Routine, Special, and Advanced Staining for the IHC Laboratory
Debra Freeman
Merck
Technical Consultant
Diagnostic immunohistochemistry, IVD manufacturing
Development of Chemiluminescent Immunoassays Based on Magnetic Beads
Anabel Lermo, Ph.D.
Pragmatic Diagnostics
Project Scientist
Food and beverage testing and manufacturing, Microbiological analysis
Environmental Monitoring in Food Industries
Anett Winkler
Merck
EMEA Regional Food Microbiologist Lead
Karin Weickel
Merck
Product Specialist Environmental Monitoring
Research and disease areas, Cancer research
Personalized T cell therapy against Hepatitis B Virus (HBV) infection and HBV-related Hepatocellular carcinoma (HCC)
This webinar will present the challenges and strategies involved in T cells engineering, how adoptive transfer of CAR-T cells can be promising immunotherapeutic option for HBV-related cancers and the future of immunotherapy in cancer treatment.
Professor Antonio Bertoletti, M.D.
Duke-Nus Medical School and Co Founder Lion TCR
Professor EID
Microbiological testing, Pyrogen testing
Monocyte Activation Test: A Powerful Tool to Assess Pyrogenic Risk in Pharmaceutical Process
In this webinar, we discuss how monocyte activation tests performed with the PyroMAT™ System detect endotoxin and non-endotoxin pyrogens.
Mathilde Arnault
Merck
Research Scientist
Genomics, Next Gen sequencing
Decreasing miRNA Sequencing Bias Using a Single Adapter and Circularization Approach
Learn Small RNA sequencing library preparation, techniques and considerations, As well as, miRNA-seq bias implications, reduction and techniques.
Sergio Barberan-Soler, Ph.D.
SomaGenics, Inc.
Director of Sequencing Technologies
Protein biology, Immunohistochemistry
Sharpshooters Guide to Troubleshooting IHC
Ourhay Shamoon
Merck
Manager, Tissue Diagnostics
Protein biology, Clinical testing and diagnostics manufacturing
IHC
This webinar focuses on advancement in immunhistochemical methods, new markers and how they fit within established diagnostic panels and a demonstration of advanced staining on clinical samples.
Jeff Gordon
Merck
OEM Sales Manager
Chemistry and synthesis, Cross coupling
Modern Catalysis: Academic Discovery to Industrial Application
Stephen L. Buchwald
Massachusetts Institute of Technology
Camille Dreyfus Professor of Chemistry
Spencer D. Dreher, PhD
MSD
Principal Scientist, Process Chemistry
Sarah L.J. Trice, PhD
Merck
Global Catalysis Portfolio Lead
Analytical chemistry, Gas chromatography
Aseptic Manufacturing
Anne-Grit Klees
Merck
Global Product Manager Environmental Monitoring
Gisela Stark-Reinhart
Merck
Global Product Manager Environmental Monitoring
Research and disease areas, Neuroscience research
Generation and Use of iPSC-derived Microglia to Study Neurodegenerative Diseases
Mathew Blurton-Jones, PhD
UC-Irvine Alzheimer’s Disease Research Center Induced Pluripotent Stem Cell (iPSC) Core
Director
Microbiological testing, Sterility testing
Importance stratégique de la surveillance microbiologique de l’environnement de fabrication pour assurer la stérilité de vos dispositifs médicaux
In this webinar, we discuss the importance of environmental monitoring during device manufacturing to ensure sterility, specifically the impact of EN 17141.
Christian Poinsot
ICARE
Président Directeur Général et Directeur Scientifique
Sabine Bessières Recasens
Environmental Monitoring Life Science Merck
Field Marketing Manager
Food and beverage testing and manufacturing, Microbiological analysis
Revised ISO 11133 and ISO 16649 Food Microbiology Standards
This webinar explains the latest changes in ISO 11133 and ISO 16649 and will give an outlook on the future of both standards.
Barbara Gerten
Merck
Senior Scientist Traditional Microbiology
Andreas Bubert, PhD
Merck
Senior Product Manager, Culture Media Food & Beverage
Analytical chemistry, Mass spectrometry
More Success in LC-MS – Tips and Tricks for Sample & Mobile Phase Preparation and Column Selection
Vivek Joshi, Ph.D.
Merck
Applications and Market Adoption Manager
Clinical testing and diagnostics manufacturing, IVD manufacturing
Optimized Lateral flow assays using dyed and fluorescent Estapor microspheres
In this webinar, we discuss the use of polymeric microspheres in diagnostic assays and share best practices to troubleshoot protein binding in qualitative assay development using our raw materials.
Hugues (Augier) de Crémiers
Merck
Application Specialist, Diagnostic Solutions, Estapor®
Food and beverage testing and manufacturing, Chemical analysis
Chemical and Microbiological Monitoring for Breweries
Dr.Fabian Zieschang
Merck
Global Product Manager
Microbiological testing, Surface and personnel testing
Hygiene Monitoring Impact of Disinfectants on ATP Results
Adèle Gisselmann
Merck
Global Product Manager Environmental Monitoring
Charlotte Lindhardt
Merck
Senior Validation Expert
Tobias Weitzel
Merck
Head of Operations
Genomics, PCR
High Precision PCR Utilizing ThermaGenix Reagents
Lawrence Wangh
ThermaGenix, Inc.
Founder and CSO
Microbiological testing, Pyrogen testing
In Vitro Pyrogen Detection in Pharma
In Vitro Pyrogen Detection in Pharma
Laure Robert
Merck
Global Product Manager